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a-vitamin requirements of ruminants must be met by the 
combination of 1) dietary a-vitamins that escape degradation 
in the rumen, and 2) microbial a-vitamin synthesis. Dietary 
supplementation studies have been the standard approach to 
investigate a-vitamin nutrition in ruminants as well as 
other livestock species. Yet dietary supplementation may 
not consistently alter duodenal a-vitamin supply and a-
vitamin status of the ruminant. Rumina! degradation of 
dietary a-vitamins can be extensive; this forces the animal 
to rely on microbial synthesis of some a-vitamins. 
Microbial a-vitamin synthesis in the rumen tends to be 
inversely related to dietary concentrations. 
Due to microbial synthesis, overt a-vitamin 
deficiencies in ruminants are unknown except for thiamin and 
for vitamin a 12 • a12 becomes deficient when feeds contain 
inadequate cobalt. However, marginal a-vitamin deficiencies 
may be important in highly productive or stressed ruminants. 
The first study was designed to assess the availability 
of eight a-vitamins in rumina! contents from steers fed 
high-concentrate diets. Semi-purifed diets lacking in 
single a-vitamins were fed to 10-day-old broiler chicks for 
2 weeks. The ability of added rumina! contents to meet 
1 
chick B-vitamin requirements was measured based on growth, 
feed efficiency, and survival of chicks. 
The second study consisted of a survey of plasma B-
vitamin concentrations in suckling beef calves, transport-
stressed cattle, feedlot cattle and high-producing dairy 
cows. From this study, baseline data were obtained for 
normal concentrations and ranges of ascorbic acid, folic 
acid, vitamin B12, B6 vitamers and pantothenic acid in 
cattle blood plasma. Concentrations were contrasted with 
those measured in other species. 
Requirements by nonruminants for certain B-vitamins 
(vitamin B6, folic acid, pantothenic acid, and ascorbic 
acid) are markedly increased by physical stress. Depletion 
of these vitamins in transport-stressed cattle could affect 
immunity and increase the incidence of bovine respiratory 
disease during the first few weeks after arrival in 
feedyards. To study this, calves were stressed by weaning, 
confinement in metabolism stalls, and restricted feeding 
followed by a 3-day fast. These processes duplicated some 
of the conditions undergone by transport-stressed calves. 
B-vitamins were supplemented by intramuscular injection of 
half of the calves. Effects of B-vitamin injections on 
plasma vitamin concentrations, resistance to bovine 
herpesvirus-! infection, and various aspects of immune 






All animals have a metabolic requirement for certain a-
vitamins. These include thiamin (a1), riboflavin ca2), 
niacin, pyridoxine (a6), pantothenic acid, folic acid, 
cyanocobalamin (a12), and biotin. In the ruminant, the 
supply of a-vitamins is determined primarily by microbial 
synthesis and(or) destruction in the rumen. Unlike other 
livestock species, ruminant a-vitamin status normally is 
unaffected by dietary a-vitamin supply. In most cases, 
supplemental a-vitamins in the diet have had little effect 
on the ruminant•s a-vitamin status; presumably, this is 
because most a-vitamins can be synthesized and destroyed in 
the rumen. 
Ruminal a-vitamin synthesis was first suggested by 
Theiler and coworkers in South Africa (1915 as cited by 
McElroy and Goss, 1941a). Theiler et al. (1925) fed a diet 
low in thiamin to cattle for 44 to 52 weeks with no evidence 
of thiamin deficiency. aechdel et al. (1926) proved that 
calves could grow to maturity and produce normal offspring 
on a diet so deficient in a-vitamins that it would not 
support life in rats. Using rat growth assays, aechdel et 
al. (1928) demonstrated that ruminal contents contained a-
vitamins, and that a bacterial isolate from the rumen 
synthesized a-vitamins in vitro. 
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Between 1925 and 1930, vitamin B, considered a single 
entity, was subdivided into several components. The term a1 
(later called thiamin) was reserved for the antineuritic 
component. First isolated in 1926, it was synthesized and 
completely characterized in 1936. The next factor 
identified was B2, also known as riboflavin. In the 1930's 
and 1940's, niacin, vitamin B6 (pyridoxine and related 
vitamers), pantothenic acid, folic acid and vitamin B12 were 
discovered to be essential a-vitamins. Development of 
assays for the specific B-vitamins speeded progress in 
understanding vitamin requirements. Initially, the vitamin 
assays used microbiological or rat and chick bioassays. 
In several studies, vitamin content of dietary and 
ruminal dry matter (DM) were compared to estimate ruminal 
vitamin synthesis. McElroy and Goss (1939: 1940a,b: 
1941a,b) first demonstrated that riboflavin, vitamin B6, 
thiamin and pantothenic acid were synthesized in the rumen. 
McElroy and Jukes (1940) similarly demonstrated biotin 
synthesis. Enrichment of the rumina! DM with riboflavin, 
nicotinic acid, pantothenic acid, pyridoxine and biotin was 
shown for both a heifer fed a vitamin-deficient synthetic 
diet and a heifer fed 6 diets containing various amounts of 
grain, linseed meal, and urea (Wegner et al., 1940, 1941). 
Thiamin clearly was more concentrated in ruminal contents 
than in the diet when a synthetic diet was fed, but not when 
5 
a practical diet was fed. Supplementation of this synthetic 
diet with 200 mg thiamin per day increased ruminal 
concentrations of all 6 B-vitamins tested. Hunt et al. 
(1941) found that thiamin concentration was greater in 
ruminal DM than in feed OM at 4 hours post-feeding in 2 out 
of 3 trials but it was lower when rumen samples were taken 
12 or more hours after feeding. They also observed that net 
synthesis of ruminal riboflavin in steers was positive when 
a mixed diet was fed but not when alfalfa hay alone was fed. 
Subsequently, further evidence was provided for synthesis of 
riboflavin but not of thiamin (Hunt et al., 1943). Ruminal 
synthesis of folic acid and biotin were demonstrated first 
by Lardinois et al. (1944) and Hale et al. (1950), 
respectively. 
Net B-vitamin synthesis was readily apparent when 
ruminants were fed purified diets (Agrawala et al., 1953; 
Virtanen, 1967). Comparison of B-vitamin intake with output 
in urine and feces of sheep, and in urine, feces and milk of 
cattle also confirmed that B-vitamins were synthesized in 
the gastrointestinal tract (Pearson et al., 1953; Porter, 
1961). 
B-vitamin synthesis occurs quite early in life of young 
ruminants given access to solid feed. In 8 to 32-day-old 
calves, the ruminal concentrations of thiamin, riboflavin, 
niacin, and folic acid were several times higher than in the 
alfalfa hay plus calf starter diet (Kesler and Knodt, 1951). 
Similarly, the ruminal concentrations of thiamin, ribo-
6 
flavin, and niacin were greater in lambs 3 weeks of age than 
in lambs 1 week of age (Buziassy and Tribe, 1960b). B-
vitamin synthesis also occurs in the large intestine in 
ruminants as in most other species. 
Quantification of a-vitamin Production. Early studies 
~ 
of ruminal B-vitamins provided a qualitative but not a 
quantitative picture of B-vitamin production. Buziassy and 
Tribe (1960a) attempted to quantitate rumen microbial 
synthesis by comparing daily B-vitamin consumption with the 
total ruminal contents of thiamin, riboflavin and nicotinic 
acid 90 minutes after feeding. They used three different 
methods to estimate ruminal volume. Synthesis was 
calculated as the difference between intake and ruminal 
content of each B-vitamin, ignoring effects of outflow, 
absorption from the rumen, and residues from previous meals. 
These workers also differed from McElroy and Goss (1940, 
1941), Wegner et al. (1940, 1941), and Hunt et al. (1941, 
1943) in using more tedious chemical rather than simpler 
microbiological assays. Buziassy and Tribe (1960a) showed 
that microbial synthesis of B-vitamins in the rumen was very 
low when the diet was rich in vitamins, but it was high when 
the diet was vitamin-deficient. 
Zinn et al. (1987) may have been the first group to 
quantitate ruminal escape and net microbial synthesis for 
each B-vitamin. They used three 194 kg. steer calves with 
cannulas in the rumen and proximal duodenum in a 3 X 3 Latin 
square. The three treatments consisted of a control diet 
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(34.5% alfalfa hay, 44.5% steam-flaked corn, sudangrass, 
molasses, fat, urea, and salt), and this diet with supple-
mental vitamins at one (X) and ten times (lOX) the estimated 
requirement. 
Their calculations were based on the assumption that 
vitamin intake and source (feed versus supplemental a-
vitamins) did not alter either microbial synthesis or the 
percentage of each vitamin destroyed in the rumen. This 
assumption conflicts with the conclusions of auziassy and 
Tribe (1960a). The extent of ruminal escape of vitamins was 
estimated from treatment means using the slope-ratio 
procedure: vitamin escape (%) = 100 X (duodenal flow of 
vitamin with nonsupplemented diet)/(vitamin intake with high 
level of supplementation - vitamin intake with non-
supplemented diet). Net microbial synthesis of various a-
vitamins was estimated by difference: vitamin synthesis 
(mgjkg digestible organic matter intake) =((duodenal vitamin 
flow - (vitamin escape/100) X vitamin intake)jkg digestible 
organic matter intake. 
In general, the daily flow of a-vitamins to the small 
intestine was increased noticeably with the lOX supplemen-
tation level but not with the X level. No difference 
between the control and X treatments were detected for any 
a-vitamin except that duodenal flow of niacin was non-
significantly depressed (from 277.4 mgjday to 207.5 mgjday) 
when intake was increased from 67.0 mg (control) to 267 mg 
(X). In contrast, the lOX level of supplementation 
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increased duodenal flow of thiamin, s6 , pantothenic acid, 
and biotin by 5 to 41 times. Niacin flow increased by 44.5% 
and folic acid flow increased by 345%, whereas the flow of 
riboflavin and B12 were not affected. These results 
indicate how rumina! synthesis and(or) microbial destruction 
can negate the effects of supplemental dietary B-vitamins on 
duodenal flow, except possibly for thiamin, B6 , pantothenic 
acid, and biotin when fed at extremely high levels. 
Factors affecting B-vitamin production 
Intake. Zinn et al. (1987) also fed 4 steers an 80% 
concentrate diet at 1.2, 1.5, 1.8, and 2.1% of bodyweight. 
The intestinal supply of each of 5 B-vitamins measured was 
correlated positively with feed intake. Daily intestinal 
supplies of thiamin, riboflavin, niacin, B6, and B12 were 
14.2, 29.4, 262.0, 19.7 and 7.5 mg, respectively, at the 
lowest feed intake versus 33.2, 49.8, 616.4, 58.1 and 12.3 
mg, respectively, at the highest intake level. 
Protein and Energy. Rumina! levels of B-vitamins often 
appear remarkably constant, despite marked differences in 
the diet and in experimental conditions. However, if 
microbial growth is limited by the supply of nutrients, 
particularly nitrogen or energy, microbial B-vitamin 
synthesis will be depressed. Nitrogen source, whether 
nonprotein N or protein, also may influence niacin 
synthesis. 
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Ruminal concentrations of thiamin, riboflavin, and 
niacin were markedly lower when the supply of N in the diet 
was low. Yet, total substitution of urea for dietary 
protein did not affect thiamin and riboflavin concentrations 
even though niacin concentration was depressed (Buziassy and 
Tribe, 1960a). 
For 16 sheep fed 8 different diets, the ruminal levels 
of riboflavin, nicotinic acid, and pantothenic acid were 
lowest when prairie hay was fed. Protein content of the 
diet and feed intake also were lowest for this diet. 
Supplementation with corn and urea increased ruminal concen-
trations of these vitamins, and substituting soybean meal 
for urea further increased niacin content (Hollis et al., 
1954). Similarly, addition of readily-available 
carbohydrate (corn, molasses, or starch) and nitrogen 
supplementation (urea or casein) increased the amounts of 
riboflavin, niacin, and pantothenic acid in the rumen 
(Lardinois et al., 1944). 
When mature grass hay was fed to young dairy calves, 
addition of grain to the diet increased ruminal B-vitamin 
levels. However, ruminal concentrations were not affected 
by the grain:hay ratio when a good quality alfalfa hay was 
fed (Conrad and Hibbs, 1954). 
Hayes (1966) compared ruminal B-vitamin levels for 
steers fed 6 cornjsoy rations. Corn processing method 
(flaked versus ground) and forage (none, long hay, ground 
hay) were compared in a 2 X 3 factorial design. Flaked corn 
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or ground corn (6.3 to 7.5 kg daily) each were fed to steers 
with no hay, 1.8 kg long hay, or 1.8 kg ground hay. A 
soybean meal supplement was included in all 6 dietary 
treatments. Riboflavin, thiamin, pantothenic acid, folic 
acid, niacin, and vitamin B12 concentrations in ruminal 
fluid varied markedly with diet. Thiamin concentration 
(16.8 ~g/100 ml) was higher (P<0.05) when the ground corn 
diet was fed than when the other 5 diets were fed; lowest 
levels (.3 ~g/100 ml) were observed when the ground 
corn/long hay diet was fed. Pantothenic acid and niacin 
were higher in rumen contents of steers fed diets without 
hay, and higher when steers were fed corn in the ground 
rather than the flaked form. Folic acid was highest in 
ruminal contents of steers fed diets without hay: its 
concentration was negatively correlated with ruminal pH. 
s12 was highest in rumen contents of steers fed the ground 
corn no-hay diet. Biotin levels varied from 2.9 to 4.8 
ug/100 mls, with no significant differences detected. 
Unfortunately, they tested no high-forage diets. 
Hunt et al. (1954) studied the effects of various 
dietary components and chlortetracycline on 4 B-vitamins in 
a series of in vitro experiments. Supplemental sulfur 
stimulated riboflavin synthesis but inhibited pantothenic 
acid synthesis. Starch stimulated the synthesis of all the 
B-vitamins studied. Cellulose stimulated synthesis of 
riboflavin more than of pantothenic acid. Chlortetracycline 
inhibited synthesis of pantothenic acid, niacin and 
riboflavin but not of B12· 
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Miller et al. (1986a) examined the effects of two 
concentrate:forage ratios and of grain source on duodenal 
flow of four B-vitamins. The high concentrate (HC) diet 
contained 88.9% corn and 10% alfalfa meal: the low 
concentrate (LC) diet contained 29.5% corn and 70% alfalfa 
meal. Both diets were fed pelleted, and resulted in similar 
ruminal OM digestibilities: thus, the LC diet would not be 
representative of typical high-forage diets. Thiamin, 
niacin, riboflavin, and biotin duodenal flows were not 
affected (P<0.05) by diet. Concentrate diets (85.5% grain) 
from corn, wheat, oats, and barley indicated a net loss of 
thiamin in the rumen: only with sorghum grain was net 
production positive although ruminal OM digestibility was 
much lower for this diet. Ruminal pH was not affected by 
diet. Although grain source altered intake of riboflavin, 
niacin and biotin, it did not affect duodenal flow of these 
vitamins. 
Diet changes can alter ruminal B-vitamin levels 
rapidly. Phillipson and Reid (1957) measured ruminal 
thiamin levels in sheep when the diet was changed. In 15 
out of 20 dietary changes, a new plateau in ruminal thiamin 
concentration was reached by the fourth day after the diet 
change. When sheep were moved to pasture at any time of 
summer, ruminal thiamin levels increased initially, 
regardless of subsequent levels. 
~eed additives. By altering rumina! fermentation, feed 
additives can affect microbial synthesis and degradation of 
B-vitamins. Effects of some dietary antibiotics have been 
studied. Feeding either 40 or 56 gjday of sulfathalidine 
increased urinary and fecal thiamin concentrations, but 
neither affected niacin, riboflavin and pantothenic acid 
concentrations (Teeri et al, 1950). Feeding 200 mg of 
procaine penicillin daily did not markedly affect rumina! 
concentrations of riboflavin, pyridoxine, biotin and s12 in 
steers fed a mixed diet (Kon and Porter, 1953). Chance et 
al. (1953 a,b) measured the effects of dietary chlortetra-
cycline (CTC) at .5 and 1 gjday for 15 days in steers. 
Although total bacterial counts were unaffected, the lower 
amount reduced riboflavin but increased niacin and 
panthothenate concentrations in rumina! contents. CTC at 
7.8 mgjkg diet, about 50 mg/d per steer, in a corn-based 
pellet did not detectably affect thiamin, ribo-flavin, or 
niacin at the duodenum, ileum, or feces; however, it 
increased duodenal and ileal biotin concentrations (Miller 
et al., 1986b). In a second trial, CTC fed at a higher 
level (70 mgjday) increased ileal (P<0.01) but not duodenal 
thiamin flow (Miller et al, 1986b). 
The effects of ionophores on rumina! B-vitamin 
metabolism have not been investigated extensively. Iono-
phores are substances that promote transfer of ions from an 
aqueous medium into a hydrophobic phase (Dobler, 1981). Two 
commonly fed carboxylic ionophores, monensin and lasalocid, 
are produced by Streptomyces cultures. Almost all feedlot 
diets and many supplements, minerals and mixed feeds fed to 
growing cattle, beef cows and non-lactating dairy cows 
contain one of these ionophores. Monensin and lasalocid may 
alter the microbial population in the rumen, affecting the 
extent and products of rumina! fermentation. They increase 
efficiency of feed use and reduce the incidence of 
coccidiosis and bloat. 
Miller et al. (1986b) measured dietary, duodenal, and 
ileal supply and fecal output of 4 vitamins in 8 steers fed 
diets supplemented with either 0 or 22 mg monensin/kg diet. 
Monensin had little effect on thiamin, except for increasing 
ileal thiamin flow (1.7 mg/d vs .a mgjd, P<0.20): it also 
tended to reduce apparent rumina! thiamin destruction (34 vs 
41%). Monensin tended to reduce rumina! niacin synthesis. 
In contrast, monensin increased riboflavin synthesis, 
tending to increase duodenal flow of riboflavin (84.3 vs 
60.8 mg/d). Monensin did not affect duodenal or ileal 
biotin flows, but it tended to increase fecal biotin output. 
Thiamin 
Thiamin occurs primarily in the form of phosphate 
esters in animal tissues, with about 80% as thiamin 
pyrophosphate (TPP), the active coenzyme form. Another 10% 
occurs as thiamin triphosphate, with trace amounts of 
monophosphate and free thiamin (Gubler, 1984). Wet tissue 
concentrations of thiamin content are highest in heart, 
kidney, liver, brain and nervous tissue. Although muscle 
concentration is relatively low, muscle contains 40 to 50% 
of total body thiamin. 
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In mammals, thiamin is involved with three major 
functions--energy metabolism, synthetic mechanisms and nerve 
conduction. The first two functions employ TPP as a 
coenzyme to transfer an activated aldehyde group. TPP is 
required for oxidative decarboxylation of a-ketoacids. 
These reactions are essential for the generation of ATP from 
pyruvate in the TCA cycle {pyruvate ~ acetyl CoA: a-
ketoglutarate~ succinyl CoA), and also for the oxidation 
of the keto-analogs of amino acids (leucine, isoleucine, 
valine) in the TCA cycle. By inhibiting carbohydrate 
metabolism, a deficiency of thiamin elevates blood lactate, 
pyruvate and oxaloacetate levels. 
The transketolase reaction of the hexose monophosphate 
shunt also requires TPP. This pathway produces pentoses for 
RNA and DNA synthesis, as well as NADPH for biosynthetic 
reactions. 
Independent of its effects on energy metabolism, 
thiamin is essential for function of the central nervous 
system; this involves thiamin triphosphate {TTP) instead of 
TPP. The brain contains a unique enzyme system which 
catalyzes the synthesis of TTP from TPP (Nishino and 
Itokawa, 1983). Thiamin levels in brain are relatively 
stable and fall only after 3 to 5 weeks of severe depletion. 
In all species, the prominent symptoms of thiamin 
deficiency are anorexia and weight loss, and irregularities 
of the heart and nervous system (Gubler, 1984). In 
ruminants, clinical signs of non-acute thiamin deficiency 
include transient scouring, ill-thrift and anorexia; these 
are associated with production losses in cattle and sheep 
(Rammel! and Hill, 1986). 
Clinical signs of a central nervous system disorder 
occur at a later stage of thiamin deficiency. The disease 
is most common in cattle, sheep and dogs, but it also 
affects goats, horses, deer and other species. The terms 
cerebrocortical necrosis (CCN) or polioencephalomalacia 
(PEM) describe the disease in ruminants. outbreaks are 
sporadic with morbidity rates from less than 10% to 50% but 
high mortality (Loew and Dunlop, 1972a). Clinical signs of 
CCN include rapid onset, aimless wandering, circling, 
hyperexcitability, incoordination, opisthotonus, recumbency, 
blindness, convulsions and coma. Because these clinical 
signs are not specific, CCN must be differentiated from lead 
poisoning, encephalitic listeriosis, bacterial meningitis, 
aflatoxicosis, hypomagnesemia, enterotoxemia, pregnancy 
toxemia, and idiopathic coccidiosis. Multiple necrotic foci 
in the cerebral cortex, and a characteristic fluorescence 
observed under the meninges in the outer cortex of a 
transverse brain section under uv illumination, confirm the 
diagnosis (Edwin et al., 1979). 
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Various dietary and management conditions can alter the 
delicate balance between thiamin production and destruction 
in the rumen and cause CCN. Thiaminases of both plant and 
microbial origin destroy thiamin. Outbreaks of CCN in the 
U.K. and Australia have resulted from livestock grazing 
fronds or rhizomes of ferns rich in thiaminase I (Evans, 
1975: Evans et al., 1975). 
Endogenous thiaminase enzymes produced by qut micro-
flora also can cause thiamin deficiency; these have been 
isolated from ruminal contents or feces from normal animals. 
Rumina! thiaminase can destroy up to 1 mg thiamin per minute 
per kg of rumen digesta (Edwin and Jackman, 1982). Two 
types of microbial thiaminase, I (EC 2.5.1.2) and II (EC 
3.5.99.2), have been isolated from rumina! contents (Evans, 
1975; Edwin and Jackman, 1970, 1982). Thiaminase I forms 
thiamin derivatives, which may act as thiamin antagonists, 
exacerbating a thiamin deficiency (Brent and Bartley, 1984; 
Edwin et al., 197Gb). Thiaminase I is markedly inhibited by 
thiamin and must be activated by a cosubstrate; cosubstrate 
affinity varies depending on the enzyme source. suitable 
cosubstrates include 0-1-pyrroline, cysteine, proline, hypo-
taurine, lysine, nicotinic acid, pyridoxine, and imidazole, 
all of which are found in rumina! fluid. Availability of 
specific cosubstrates may be critical to the development of 
CCN (Bakker et al., 1980). CCN has been precipitated by 
administration of levamisole hydrochloride or thiabendazole, 
anthelminths that can act as thiaminase I cosubstrates 
(Linklater et al., 1977). 
17 
CCN occurs most frequently in grain-fed animals 
susceptible to lactic acidosis: diets rich in readily 
fermented carbohydrates have been fed to induce CCN. Many 
bacterial species including Bacillus thiaminolyticus, 
Clostridium sporogenes, and Megasphaera elsdenii, produce 
thiaminase I. The bacterial thiaminase I is an exoenzyme 
bound to the cell surface; little or no activity occurs in 
the cell-free fluid from normal animals at pH 6.8; in fact, 
net synthesis of thiamin may be positive. But, if rumina! 
contents are "acid shocked" in vitro to pH 4.5 and then 
adjusted to pH 6.8, free thiaminase is found in rumina! 
fluid (Sapienza, 1981). In sheep affected with CCN, the 
enzyme was found primarily in the supernatant fluid, 
presumably due to lactic acidosis (Brent and Bartley, 1984). 
Lactic acidosis also increases histamine in rumina! 
contents; histamine is an active cofactor for thiaminase I. 
Thiaminase II is a hydrolytic enzyme that cleaves 
thiamin into pyrimidin and thiazole components without 
forming analogs; it does not require a cosubstrate (Harmeyer 
and Kollenkirchen, 1989). While thiaminase II has been 
identified in rumina! contents (Edwin and Jackman, 1982), 
Bakker et al. (1980) and Edwin and Jackman (1970) isolated 
only thiaminase I from animals affected with CCN. 
High sulfate levels in the diet or water can increase 
the incidence of CCN. The sulfite ion, produced during the 
microbial reduction of sulfates to sulfides, can destroy 
thiamin (Zoltewicz et al., 1982). CCN has occurred in 
cattle fed grain preserved with sulfur dioxide {Gibson et 
al., 1986) and in cattle fed diets containing calcium 
sulfate (gypsum) or MgKS04 as an intake limiter (Brent and 
Bartley, 1984). 
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Amprolium, a feed additive used to prevent coccidiosis 
in ruminants and chicks, is a thiamin analog. It has a 
pyrimidine ring similar to thiamin but, lacking the hydroxyl 
group, it does not act as a substrate for thiamin pyrophos-
phokinase; hence, it does not inhibit TPP-dependent enzymes. 
Nevertheless, amprolium inhibits thiamin transport across 
microbial cell walls; this is the basis of its anticoccidial 
action. Amprolium also can affect thiamin transport across 
the intestinal wall, causing thiamin deficiency and PEM 
(Loew and Dunlop, 1972b; Gubler, 1984). 
Several methods have been used to assess thiamin status 
in animals and man; these include blood thiamin, pyruvate 
and lactate levels, the response of blood transketolase to 
added thiamin (TPP effect), and urinary thiamin excretion. 
Blood thiamin levels can be useful if they reflect 
tissue levels, as has been shown in nonruminant animals fed 
deficient diets. Blood contains about .8% of the total body 
thiamin, and the concentration is very low (6 to 12 ~g/100 
ml). Most of the blood thiamin is located in the erythro-
cytes and leukocytes, so serum levels are even lower. As a 
result of technical difficulties in measuring serum levels, 
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the indirect method of assessing thiamin status through 
transketolase activity became most popular and is still 
extensively used in human nutrition. However, numerous HPLC 
methods for measuring thiamin in blood and tissue are 
available. 
Ri~flavin 
Riboflavin occurs in feeds in the form of free 
riboflavin, FMN, and FAD. Any of these three forms can 
fulfill the vitamin requirement. In mammalian tissues, 
riboflavin exists primarily as FAD and FMN although 
riboflavin is found free in the eye and the urine. 
The riboflavin coenzymes FMN and FAD act as 
intermediates in the transfer of electrons in biological 
oxidation-reduction reactions. Those that function 
aerobically are called oxidases; those that function 
anaerobically are called dehydrogenases. 
The oxidases are soluble enzymes found in the cell 
cytoplasm; they transfer hydrogen to molecular oxygen to 
form hydrogen peroxide. The best known oxidase, Warburg's 
old yellow enzyme, is an FMN-containing flavoprotein that 
oxidizes glucose to gluconic acid. 
The flavoproteins that function anaerobically link 
substrate oxidation with phosphorylation and ATP synthesis. 
This pathway usually involves NAD, cytochromes, and the 
transfer of hydrogen from substrate oxidation to form water. 
Two ATP are generated for each hydrogen passed directly from 
the substrate to a flavoprotein (e.g., succinic dehydrogen-
ase) whereas 3 ATP are formed when hydrogen is transfered 
first from the substrate to HAD and later to FAD and the 
cytochrome system (e.g., cytochrome reductase). Other 
important flavoproteins include the acyl-coenzyme A 
dehydrogenases for fatty acid oxidation. Mitochondrial 2-
glycerophosphate dehydrogenase and lactic acid dehydrogenase 
are part of shuttle mechanisms in which reducing equivalents 
are passed from the cytoplasm to the mitochondria. 
Pyridoxine 
Vitamin B6 is the generic term for all 3-hydroxy-2-
methyl pyridine derivatives. The trivial names and acronyms 
for the 3 principal forms of vitamin B6 and their phosphate 
esters are: pyridoxine or pyridoxol, PN; pyridoxal, PL; 
pyridoxamine, PM; pyridoxine 5 1 -phosphate, PNP; pyridoxal 
5 1 -phosphate, PLP; and pyridoxamine 5 1 -phosphate, PMP. 
These forms of vitamin a6 are interconvertible in animal 
tissues. 
Pyridoxal phosphate is the coenzyme form of vitamin B6· 
It participates in reactions of more than 100 enzymes, 
nearing half involving transamination reactions. During 
transamination reactions, pyridoxal phosphate is transformed 
reversibly into pyridoxamine phosphate (Snell, 1986). PLP 
is involved in numerous other reactions in the metabolism 
(synthesis and catabolism) of a-amino acids. These include 
nonoxidative deaminations, decarboxylations, and desulfhy-
dration reactions. 
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PLP affects gluconeogenesis in two ways: first as the 
coenzyme for transamination reactions, and second as a 
component of glycogen phosphorylase. In rats, a deficiency 
of vitamin 86 has decreased liver and muscle glycogen 
phosphorylase (Angel and Moller, 1974). 
PLP affects erythrocyte function and metabolism. PLP 
is the coenzyme for o-aminoleuvulinic acid synthetase; this 
synthetase forms o-aminoleuvulinic acid, a precursor of 
heme. Consequently, a vitamin 86 deficiency in animals may 
result in a hypochromic, microcytic anemia. PLP and PL bind 
to specific chains of hemoglobin, altering o2 binding 
affinity. PLP also is the coenzyme for various erythrocyte 
transaminases; this forms the basis for several enzymatic 
assays of vitamin s6 status. 
The immune system can be influenced by PLP. Vitamin B6 
deficiency can depress lymphocyte production (van den Berg 
et al., 1988), antibody response (Chandra and Puri, 1985), 
and cell mediated immunity (Cheslock and McCully, 1960). 
PLP is the coenzyme for a key enzyme involved in 1-carbon 
metabolism, serine transhydroxymethlase, which affects 
nucleic acid synthesis. Via this mechanism, vitamin 86 
status may alter immune function. 
PLP participates in multiple enzymatic reactions in the 
complex tryptophan-niacin pathway. on a low vitamin 86 
diet, niacin formation from tryptophan is depressed. 
Thereby, urinary excretion of niacin metabolites after a 
tryptophan load can be used to evaluate vitamin s6 status in 
humans (Leklem, 1991). 
Vitamin B6 affects the nervous system. Neurotrans-
mitters including serotonin, dopamine, norepinephrine, and 
histamine are synthesized by PLP-dependent enzymes. Decar-
boxylation of glutamic acid to GABA, and degradation of 
GABA, both involve PLP-dependent enzymes. GABA is involved 
in the regulation of synaptic transmission in the nervous 
system (Driskell, 1984). Vitamin s6 deficiency results in 
convulsions, abnormal EEGs, and structural and biochemical 
changes in the brain (Leklem, 1991). 
Lipid metabolism also is affected by vitamin s 6 status 
although the mechanism is poorly understood. Vitamin s6 may 
modify methionine metabolism, indirectly affecting phospho-
lipid and fatty acid metabolism (Loo and Smith, 1986) and 
carnitine synthesis (Cho and Leklem, 1990). 
Recently, PLP has been shown to modulate steroid action 
(Litwack et al., 1985; Cidlowski and Thanassi, 1981). PLP 
reacts with steroid receptors for estrogen, androgen, 
progesterone and glucocorticoids. B6 status may alter 
sensitivity of the end-target tissue to steroids. The 
physiological significance of this alteration has not been 
established (Leklem, 1991). 
Vitamin s 6 is required or stimulatory for certain 
ruminal microbes including Ruminococcus albus, ~ 
flavefaciens, Butyrivibrio fibrisolvens, and Megasphaera 
elsdenii. aacteroides succinogenes and B. amylophilus do 
not require vitamin B6 (Wolin and Miller, 1988). 
The effect of diet composition on ruminal B6 synthesis 
has not been studied in detail. Increasing the nitrogen 
concentration of the feed did not affect vitamin B6 in the 
rumen in two studies (Wegner et al., 1941; Lardinois et al., 
1944). Ruminal vitamin B6 concentrations have ranged from 8 
to 10 mgjkg rumen DM (McElroy and Goss, 1940b) and 3 to 12 
mgjkg DM (Wegner et al., 1940, 1941). 
Dietary vitamin B6 appears to escape ruminal 
degradation; in addition, microbial B6 is synthesized in the 
rumen (Zinn et al., 1987). Comparison of ruminal levels or 
duodenal flows of vitamin B6 with non-ruminant requirements 
reveals that vitamin B6 requirements should normally by 
supplied. However, Horst and Reinhardt (1983) speculated 
that a transient deficiency of vitamin B6 could potentiate 
the negative effect of glucocorticoids on intestinal calcium 
absorption, increasing the incidence of milk fever in cows. 
Physical symptoms of deficiency in nonruminants include 
symmetrical scaling dermatitis, poor growth, muscle weak-
ness, hyperirritability, and altered activity and curiosity 
scores. Anemia, fatty liver, nerve degeneration, and 
decreased reproduction also are seen. Depressed antibody, 
nucleic acid, and protein synthesis are characteristic 
(Driskell, 1984). 
Vitamin B6 deficiency has not been identified in adult 
ruminants under practical conditions. Vitamin B6 deficiency 
symptoms in the preruminant calf included loss of appetite, 
and slowing and cessation of growth. Diarrhea and "fits" 
occurred in some calves. Post-mortem examinations showed 
enteritis, inflammation of lymph nodes, and demyelination of 
peripheral nerves (Johnson et al., 1950). 
Pyridoxine and pyridoxamine and their phosphorylated 
forms are the predominant vitamin B6 forms found in plants. 
PLP predominates in most animal feeds. Other conjugated 
forms of pyridoxine occur, such as the glycosylated form in 
wheat bran. In humans, the level of glycosylated vitamin a6 
in foods was correlated inversely with vitamin B6 
bioavailability (Leklem, 1991). 
Phosphorylated forms of vitamin B6 are hydrolyzed by 
alkaline phosphatase in the intestine. Absorption in rats 
appears to be a nonsaturable, passive process primarily 
restricted to the small intestine. Recently, an active 
absorption process was proposed (Middleton, 1985). 
The liver is the organ primarily responsible for 
metabolism of vitamin B6· The B6 vitamers are inter-
converted in the liver; the active form, PLP, is released 
into the circulation for other tissues (Lummeng and Li, 
1980; Lumeng et al., 1974). PLP formed in liver and other 
tissues binds via a Schiff base reaction with proteins. 
This PLP binding may metabolically trap vitamin B6 in cells 
(Lummeng and LI, 1980). 
PLP released from the liver is found in the plasma 
bound to albumin. Binding to albumin protects PLP from 
hydrolysis and enables it to be delivered to other tissues. -
PLP is the most abundant B6 vitamer found in the plasma, but 
PN, PMP and PM also are found. 
Erythrocytes are involved in metabolism and transport 
of vitamin B6. PL and PN are absorbed rapidly by the 
erythrocyte through simple diffusion; PL binds more tightly 
to hemoglobin than to albumin. The PL concentration is 4 to 
5 times greater in the erythrocyte than in plasma. PN and 
PL are converted to PLP in the human erythrocyte. The role 
of the erythrocyte in transporting vitamin B6 is not clear, 
particularly due to the tight binding of hemoglobin to PLP 
and PL (Leklem, 1991). 
Research with humans suggests that most (85 to 90%) of 
the vitamin B6 in the body is located in muscle, mainly as 
PLP bound to glycogen phosphorylase (Krebs and Fischer, 
1964; Coburn et al., 1988). In contrast, only 10% of liver 
vitamin B6 is bound to glycogen phosphorylase. Muscle may 
be a storage site for vitamin a6 • Studies in animals and 
humans suggest that muscle a6 is released during times of 
decreased caloric intake or increased gluconeogenesis, not 
as a direct response to the vitamin a6 requirement (Black et 
al., 1978; Russell et al., 1985; Leklem, 1985). 
Vitamin B12 
Vitamin s12 is the generic name for all corrinoids 
exhibiting the biological activity of cyanocobalamin. 
cyanocobalamin is both widely available and most stable, so 
is the primary form of supplemental B12 used. 
Cobalamins are primitive coenzymes that were in their 
prime when oxygen was scarce and have been declining in 
biological significance since that time (Bradbeer, 1982). 
Higher plants do not use cobalamins; this is fortunate as 
these coenzymes are light and oxygen sensitive; animals have 
retained only two cobalamin coenzymes. However, cobalamin-
dependent reactions prevail in microbes, particularly those 
in dark, anaerobic environments. 
Of all B-vitamins, Vitamin B12 is the largest and most 
complex molecule. Many different analogs and derivatives 
exist. Althought many of the naturally occurring analogs 
have biological activity for microorganisms, most analogs 
are inactive in animals. Analogs of s12 may interfere with 
(1) cobalamin uptake, (2) formation of coenzyme forms or (3) 
binding action of the coenzymes. 
Coates and his colleagues at the National Institute for 
Research in Dairying in England initiated most of the early 
work with vitamin B12 analogs. They had found that the s12 
in rumina! contents and feces was less active for chicks 
than had beem indicated by the mutant E. coli assay. This 
led to the identification of three compounds structurally 
similar to cyanocobalamin. Originally termed factors A,B, 
and C, they differed from cyanocobalamin in having 2-
methyladenine, no base, and guanine, respectively, as the 
base of the nucleotide instead of 5,6-dimethylbenzimidazole. 
In spite of ruminal production of vitamin 812 analogs, 
812 def~ciency in ruminants has not been described except 
when cobalt is deficient in the feed. 
The coenzyme forms of vitamin 812 in animals are 
adenosylcobalamin and methylcobalamin. These plus hydroxo-
cobalamin are the major cobalamins found in animal tissues. 
Only three 812-dependent enzymes are known in mammalian 
systems. Methylmalonyl-CoA CoA-carbonyl mutase (E.C. 
5.4.99.2) is crucial to the metabolism of propionate by 
animal tissue. It isomerizes R-methylmalonyl CoA (derived 
from propionate, and also from the degradation of iso-
leucine, branched chain fatty acids, and fatty acids with an 
odd number of carbons) to succinyl CoA. A cytoplasmic 
enzyme, 5-methyl-H4-folate homocysteine methyltransferase is 
required for the biosynthesis of methionine from homo-
cysteine. L-leucine-2,3-aminomutase is widely distributed 
in nature and important in leucine metabolism, although its 
functions in mammals have not been clarified. 
B-Vitamins in Immune Response 
The direct relationship of B-vitamin nutriture and 
immunocompetence has not been explored in ruminant animals. 
Therefore, we must rely on data from non-ruminant animals. 
In non-ruminant animals, certain a-vitamin deficiencies 
increase susceptibility to bacterial infection. Specific 
changes in the metabolism of a-vitamins also can occur early 
in the development of chronic disease. Pyridoxine, 
pantothenic acid and folic acid are especially important a-
vitamins in the immune response. Body stores of all three, 
and especially pyridoxine, are readily depleted. 
Pyridoxine status has a profound impact on the immune 
system due to its critical role as pyridoxal-5-phosphate. 
Pyridoxine deficiency reduces DNA synthesis; consequently, 
RNA (particularly mRNA) and protein synthesis are reduced. 
Because the immunologic response to an antigen requires 
synthesis of protein, RNA and DNA for cell transformation 
and replication, the immune response can be retarded or 
blocked when pyridoxine is deficient. 
Pyridoxine deficiency affects lymphoid tissues, 
especially the thymus. Deficiency causes thymic involution, 
and lymphocyte depletion in the thymus, spleen and lymph 
nodes (Clark and Stoerk, 1956); peripheral blood lymphopenia 
often is observed (Gross and Newberne, 1976). 
Antibody production is extremely sensitive to 
pyridoxine deficiency. Many investigators, using a variety 
of experimental species and antigens, have observed this 
impairment of the antibody response. Pyridoxine is required 
during both the primary and secondary phase of the antibody 
response to diphtheria toxoid in rats. Moreover, deficiency 
during the primary immunization phase caused an impairment 
of the secondary phase which could not be corrected with 
pyridoxine therapy (Pruzansky and Axelrod, 1955). In a 
study using the thymus-dependent antigen, sheep red blood 
cells (SRBC), splenic antibody-forming cells in rats were 
markedly reduced after primary immunization with SRBC (Kumar 
and Axelrod, 1968). A combination of pyridoxine and 
pantothenate deficiencies virtually eliminated the antibody 
response (Hodges et al., 1962). 
T-lymphocyte function and cell-mediated immunity also 
are impaired by pyridoxine deficiency, as evidenced by 
prolonged allograft survival, reduced mixed leukocyte 
reactivity, and poor delayed type hypersensitivity reactions 
(Axelrod et al., 1958; Robson and Schwartz, 1975). 
Pyridoxine supplementation in excess of requirements 
can prove beneficial. In mice, high dietary pyridoxine 
increased oxygen radical production of both blood and spleen 
phagocytic cells, and increased B-lymphocyte proliferation 
response to polysaccharide (Gebhard et al., 1990). These 
workers suggested that tumor inhibition by high dietary 
pyridoxine may be mediated by T lymphocyte-dependent 
mechanisms, because it did not occur in athymic mice. High 
dietary pyridoxine also enhanced cell-mediated immunity 
measured by footpad swelling of mice; response was decreased 
in deficient mice. In vitro, pyridoxine supplementation of 
the culture medium increased stimulation of spleen cells by 
phytohaemagglutinin (Gridley et al., 1988). 
Pantothenic Acid deficiency also can depress antibody 
production. Antibody responses to Salmonella pullorum 
antigen and human O+RBC were markedly depressed in 
pantothenate-deficient swine (Harmon et al., 1963). Both 
the primary and secondary antibody response to diphtheria 
toxoid was impaired by a pantothenate deficiency in rats 
(Axelrod, 1971). In deficient rats, the primary antibody-
forming cell response and primary hemolysin antibody 
response to SRBC were severely decreased. Also, primary 
splenic antibody-forming cells were reduced (Lederer et al., 
1975). These workers found that the secretion of proteins 
into extracellular space was blocked by a pantothenic acid 
deficiency. T-lymphocyte and cell-mediated immunity, 
however, were not affected by pantothenate deficiency. 
Folic Acid functions in the metabolism of nucleic 
acids, protein, amino acids and phospholipids. Because 
folic acid is critical to cell growth and reproduction, a 
deficiency affects host resistance and immune function. 
Folate-deficient experimental animals are more susceptible 
to bacterial infections (Chvapil, 1973: Chvapil, 1976). 
Folate deficiency impairs both T-lymphocyte and B-lymphocyte 
functions, depresses antibody production, and reduces 
delayed type hypersensitivity responses (Stinnett, 1983). 
Even a marginal folic acid deficiency may cause a measurable 
drop in mitogenic response, cytotoxic killing function, and 
T-cell-dependent B-cell function (Gross and Newberne, 1980). 
Effects of stress and Disease on B-vitamin Requirements 
With the exception of vitamin B12, B-vitamins are not 
warehoused in the body. They are depleted rapidly during 
periods of increased demand or reduced availability. B-
vitamin flow at the duodenum increased as feed intake 
increased, mainly due to increased microbial synthesis (Zinn 
et al, 1987). Therefore, animals with reduced feed intake 
are particularly at risk, even if rumina! metabolism is 
normal. 
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Little information is available on the influence of 
stress on a-vitamin requirements in livestock. In qeneral, 
poultry and swine under field conditions will not thrive 
when fed only the minimum NRC recommended levels for 
vitamins; animals grown under unstressed research conditions 
may require less than animals produced commercially 
(McNaughton, 1990). Levels of B-vitamins used commercially 
often exceed the NRC requirements by up to ten times; this 
is an attempt to meet added needs due to high production, 
stress and subclinical disease. In support of an altered 
requirement, a summary of research with humans indicates 
that requirements for some B-vitamins are markedly increased 
above normal by even "moderate injury" (Mueller and Thomas, 
1975). Folic acid and pantothenic acid requirements were 
increased 15 and 4-fold, respectively by moderate injury; 
the pyridoxine requirement was increased 20-fold with severe 
injury. Stress-induced immunosuppression in patients 
awaiting surgery was assessed by lymphocyte proliferation. 
Oral treatment with 600 mg thiamin disulfide, 1200 mg 
pyridoxine hydrochloride, and 1.2 mg cyanocobalamin weekly 
for 7 weeks prevented immunosuppression (Lettko and Meuer, 
1990). In severe illness, much of the plasma pyridoxal 5 1 -
phosphate (PLP) may be tightly bound and unavailable; free 
plasma PLP concentration alone has been used successfully to 
predict survival of seriously ill surgical patients. 
survival has been improved with pyridoxine supplementation 
(Enriquez et al., 1988; Keniston et al., 1990). Increased 
need for B6, folic acid and pantothenic acid under stress 
conditions makes them of particular concern, especially 
considering their involvement in the immune response. 
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In cattle, stress is one of the major components in the 
etiology of the Bovine Respiratory Disease complex (BRD). 
The Bovine Respiratory Disease Complex is responsible for 
approximately 75% of morbidity and mortality in feedlot 
cattle (Jensen et al., 1976). This disease results in 
economic losses due to added veterinary costs and medica-
tions, as well as reduced rate and efficiency of gain, and 
death. The total cost to the cattle industry in the u.s. 
may exceed one-half billion dollars annually (McMillan, 
1983). 
BRD involves infection by any of ten bovine viruses 
(primarily bovine herpesvirus-1, parainfluenza-3, and bovine 
viral diarrhea) followed usually by infection with 
Pasteurella haemolytica (Rosenquist, 1984). As in other 
species including man, virus infections predispose cattle to 
bacterial infections (Babiuk, 1984; Jakab, 1984). 
Numerous stressors during the shipping/marketing cycle 
predispose cattle to a high incidence of BRD during the 
first 3 weeks after arrival at the feedyard (Kelly and 
Janzen, 1986). Stress can increase disease susceptibility 
through several mechanisms. Adrenocorticotropic hormone is 
released from the anterior pituitary gland in response to 
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stress; it stimulates the adrenal cortex to increase the 
synthesis and excretion of cortisol (hydrocortisone). 
Cortisol and other glucocorticoids have been shown to 
suppress the immune response in cattle and other species 
(Roth, 19854; Golub and Gershwin, 1985). Shipping is a 
primary stressor; serum cortisol levels were increased for 4 
to 7 days by trucking compared to less than 2 days by 
weaning (Von Tungeln, 1986; Crookshank et al., 1979). 
Cattle frequently are shipped long distances in the u.s.; in 
one survey, more than half of cattle in Texas feedyards had 
been shipped more than 1000 miles (McMillan, 1984). 
Cortisol mediates immunosuppression through an inter-
action with glucocorticoid receptors on leukocytes (Roth, 
1985). High plasma cortisol concentrations, by impairing 
neutrophil function, inhibit the first line of defense 
against infection. Macrophages and monocytes also are 
sensitive to glucocorticoids. Furthermore, concentrations 
of serum antibodies and various soluble immunoregulatory 
factors may be affected by glucocorticoids. 
One role for vitamin B6 is modulating the cortisol-
induced effects of stress; vitamin B6, by blocking cortisol 
as it blocks other steroid hormones, may modulate hormonal 
action. Steroid hormones affect expression of specific 
target genes through interaction with specific receptor 
proteins to form a complex. This complex localizes to the 
nucleus, associating there with specific DNA sequences to 
modulate expression of certain gene~ (Allgood et al., 1990}. 
Pyridoxal phosphate affects biochemical properties of ster-
oid hormone receptors, and affects subcellular localization 
and DNA binding of these receptors. Animal studies indicate 
that translocation of steroid receptor complexes from the 
cytoplasm to the nucleus is enhanced by a vitamin s6 
deficiency and decreased by elevated vitamin concentrations 
(Holley et al., 1983: Symes et al., 1984: Bunce and Vessal, 
1987). 
Stress affects immunity in various ways in addition to 
cortisol. Transport and marketing indirectly affect disease 
susceptibility through nutrition. Immunity depends on cell 
proliferation: therefore, it is intensely sensitive to 
nutrient deficiencies or imbalance (Golub and Gershwin, 
1985). Transport and marketing involve periods of feed and 
water deprivation, dietary changes, weight loss and 
dehydration. Other stresses such as transport exacerbate 
these problems (Von Tungeln, 1986). Extent of weight loss 
during transit (shrink) appears to be correlated with 
morbidity and mortality in feedlot cattle (Griffin, 1983). 
Nutrition problems may continue during the first weeks 
after arrival. Digestive capacity is lost during shipping 
and marketing due to reduced rumina! volume, altered 
microbial populations, and impaired function (Damron et al., 
1979: Hamlett et al., 1983; Koers et al., 1974). As a 
result, appetite and intake recover slowly. 
various studies have shown that disease resistance of 
receiving cattle can be influenced by management and 
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nutrition prior to shipping and during the critical 14 to 28 
days post-arrival (Hutcheson and Cole, 1986). However, the 
role of individual nutrients, including B-vitamins is 
unclear; most studies have involved the comparison of feeds 
or feed combinations. Studies involving the addition of B-
vitamin mixtures to the diet have had variable results (Cole 
et al., 1979; Lee et al., 1985; Zinn et al., 1987). Reasons 
include 1) the low B-vitamin levels fed, 2) ruminal 
degradation of dietary B-vitamin sources, and 3) failure to 
influence B-vitamin status of the animal. B-vitamin status 
in response to supplementation has not been measured. 
Considering these problems, the several reports that supple-
mental B-vitamins have reduced morbidity of receiving calves 
are encouraging. 
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CHAPTER III 
RUMEN CONTENTS AS A SOURCE OF B-VITAMINS FOR CHICKS 
P.L. Dubeski and F.N. owens 
ABSTRACT 
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Chick growth and survival were monitored as indices of the 
a-vitamins supplied by wet ruminal contents. Ten diets were 
formulated containing all, none, or all but one of each of 
eight a-vitamins. These diets were fed with and without 
addition of liquid ruminal contents to test the ability of 
the ruminal contents to meet the chick's requirement for 
each a-vitamin. Compared to requirements for chicks, 
ruminal contents of steers fed concentrate diets contained 
37, 500, 160, 244, 309, 207, 72 and 15,300% of the chick's 
total needs for thiamin, riboflavin, vitamin a 6 , niacin, 
pantothenic acid, folic acid, choline and vitamin B12. 
Based on chick requirements, the concentration of a-vitamins 
in ruminal contents was low for thiamin and choline but 
adequate for all the other a-vitamins. Added ruminal 
contents increased gain and efficiency for each vitamin 
deficient diet as expected except for the vitamin B12 and 
pantothenate-deficient diets. Vitamin status of cattle fed 
high concentrate diets may be impaired by the antagonism of 
vitamin a 12 analogs, the low availability of pantothenic 
acid, and the low concentrations of thiamin. 
Introduction 
Because dietary supplementation typically has failed to 
improve performance of ruminants, nutritionists have 
concluded that extensive microbial production of a-vitamins 
in the rumen exceeds ruminant requirements. Consequently, 
the many dietary factors affecting ruminal a-vitamin 
synthesis have not been well characterized. Further, the 
availability of a-vitamins in rumen contents has not been 
investigated, particularly for cattle fed high-concentrate 
diets. 
Ruminal production and degradation of a-vitamins have 
been studied previously at Oklahoma State (Zinn et al., 
1987). Duodenal flow of pantothenic acid and folic acid 
were less than 10% of estimated requirements. In contrast, 
supply of other a-vitamins (thiamin, riboflavin, niacin, 
pyridoxine and vitamin a12> grossly exceeded estimated 
requirements at normal feed intake levels. Whether or not 
these vitamins were all present in a form available for 
animals, whether heat drying duodenal contents prior to 
analysis might have altered calculated supplies, and whether 
duodenal flow fully appraises ruminal a-vitamin yield, is 
not clear. 
Generally, a-vitamin requirements of ruminants are 
higher when animals are young and growing rapidly. 
Mechanisms of absorption, post-absorptive transport, 
metabolism and excretion are thought to be similar in 
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ruminants and non-ruminants (Harmeyer and Kollenkirchen, 
1989). We used chicks to assess the adequacy of available 
B-vitamins in ruminal contents. Chicks have been used as a 
bioassay for many nutrients, including many B-vitamins. 
Because of their rapid growth, chicks exhibit deficiencies 
rapidly. Using chicks, we attempted to identify which a-
vitamins potentially might limit performance of rapidly-
growing young ruminants fed a high-concentrate diet. 
Materials and Methods 
Preliminary study. A preliminary study was conducted to 
test 1) the semi-purified diet formula and 2) the 
consumption of this diet mixed with rumina! contents. Dry 
matter intake, survival, and weight gain were measured for 
chicks fed semi-purified diets supplemented with all or none 
of the B-vitamins, and fed either dry alone or mixed with 
wet ruminal contents. Chicks readily consumed all four 
diets. Ten-day-old chicks thrived when fed for 2 weeks on a 
diet complete in B-vitamins, whether dry or mixed with 
ruminal contents. The B-vitamin deficient diet resulted in 
poor weight gain and feed efficiency, with substantial 
mortality occurring in chicks after one week on the diet. 
Addition of rumina! contents to the deficient diet improved 
performance and reduced mortality significantly (P < .05). 
Chicks. One thousand one day old Cobb X Cobb (broiler) 
cockerels were purchased and raised in batteries on a 
standard corn-soybean meal diet until they were 9 days of 
age. The vitamins used were provided at typical industry 
levels in a broiler premix manufactured by Hoffman LaRoche 
(Table 1). Each chick was wing banded for identifcation and 
640 chicks were randomly allocated to 80 pens in 8 batteries 
in the OSU. Chick Lab, with 4 pens of 8 chicks fed each 
diet. The chicks were fed their test diets for 14 days from 
10 to 25 days of age. 
Diets. Ten semi-purified diets were formulated from corn 
starch, vitamin-free casein, minerals, vitamins and corn oil 
(Table 2). A cornstarch premix was prepared for each a-
vitamin to provide the same supplemental a-vitamin levels as 
in the starter cornjsoy diet when added at .33% of the diet 
(Table 2). Vitamin-deficient diets were prepared by 
replacing these premix(es) with cornstarch. The COMPLETE 
diet was supplemented with all a-vitamins; the DEVOID diet 
was devoid of all supplemental a-vitamins with the exception 
of biotin. The eight other diets were formulated to be 
deficient only in one a-vitamin (either thiamin, riboflavin, 
niacin, pyridoxine, pantothenic acid, folic acid, vitamin 
a12' or choline). Each diet was fed in two forms, 1) dry or 
without added ruminal contents (RC-) and 2) mixed with wet 
ruminal contents (RC+) at a rate of about 55 g wet ruminal 
contents to 45 g dry semipurified diet. 
Ruminal contents were obtained from 5 mature 600 kg. 
rumen-cannulated beef cattle adapted to a high concentrate 
diet. Each animal was fed 7 kg. concentrate plus .9 kg 
prairie hay daily in 2 feedings, and had access to salt and 
Table 1. Composition of starter diet 
Ingredient 
Corn, ground 
Soybean meal 49% 


















avitamin premix provided per kg feed: 10,000 IU vitamin 
A, 2,500 IU vitamin o3 , 50 IU vitamin E, 2 mg menadione, 
2.0 ppm thiamin, 6.6 ppm riboflavin, 33 ppm niacin, 3.96 
ppm pyridoxine, 11 ppm pantothenic acid, 1.1 ppm folic 
acid, .019 ppm B12, and .35 ppm biotin. 
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Table 2. Composition of complete diet 











Vitamin ADEK premixC 
Thiamine hydrochloride premixd 
Riboflavin premixd 
Niacinamide premixd 
Pyridoxine hydrochloride premixd 
Calcium D-pantothenate premixd 
Folic acid premixd 





















aGlista salts (TD#88178, Teklad Premier Laboratory 
Diets, Madison, WI) provided dietary levels of 1.16% ca, 
.64% P, .404% K, .35% Na, 600 ppm Mg, 212 ppm Mn, .1 ppm 
Se, 56 ppm Zn, 10 ppm cu, 5 ppm I, 84 ppm Fe, 5350 ppm Cl, 
0.058% S, and .2 ppm Co. 
bcitric acid (anhydrous) was included at 1% of diet to 
prevent microbial growth. 
cvitamin ADEK premix (Teklad) provided 10,000 IU vitamin 
A, 2,500 IU vitamin o3 , 50 IU vitamin E and 2 mg menadione 
per kg. 
din the complete diet, added B-vitamins were supplied at 
2.0 ppm thiamin, 6.6 ppm riboflavin, 33 ppm niacin, 3.96 
ppm pyridoxine, 11 ppm pantothenic acid, 1.1 ppm folic 
acid, and .019 ppm B12 . In vitamin deficient diets were 
made by replacing the vitamin premix(es) with an equivalent 
amount of corn starch. 
eBiotin was present in all diets at .35 ppm. 
water. Rumina! contents (approximately 50 liters) were 
sampled from 2 of the 5 animals each day; the same animal 
was not used on 2 successive days. 
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Froth was skimmed off the rumen contents; then, the 
fluid was squeezed through 2 layers of cheesecloth. The 
solids caught by the cheesecloth were ground in a Waring 
blender, and remixed with the remaining fluid. Rumina! 
contents were sampled and analyzed for dry matter; samples 
were frozen, lyophilized and composited for a-vitamin 
analysis. a-vitamin concentrations in rumina! contents were 
analyzed (Woodson-Tenent Laboratories, Inc., Memphis, TN). 
Preparation and analysis of diets. Each diet containing 
rumina! contents (RC+) was mixed fresh daily. Each diet was 
sampled in duplicate daily and analyzed for dry matter. On 
the average, RC+ diets contained (wet basis) 42.75% diet and 
57.25% rumina! contents. The RC+ diets had an average dry 
matter concentration of 46.4%. Based on the DM percentage 
in rumina! contents (10%), only 12.4% of the diet DM was 
supplied by rumina! contents. 
Data Collection. The chicks were weighed at 10, 17 and 24 
days of age (dO, d7 and d14 of the study) after an overnight 
fast. Mortality was recorded daily. Daily dry matter 
intake per pen was calculated from initial and final feed 
weights, and duplicate dry matter analyses of orts. 
Results and Discussion 
a-vitamin concentrations in rumina! contents, the chick 
a-vitamin requirement, and the percentage of the chick 
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requirements supplied by ruminal contents are shown in Table 
3. Nutrient requirements are highest for young animals 
gaining at a relatively high percentage of their body 
weight. Per unit of dry matter, requirements for many 
nutrients such as a-vitamins therefore decline as animals 
mature because requirements for maintenance are lower than 
requirements for weight gain or production. a-vitamin 
requirements per unit of metabolic weight should be somewhat 
lower for cattle, depending on the stage of growth, than for 
the 10-day-old chick. However, assuming adequate bioavail-
ability, comparison of ruminal a-vitamin concentrations with 
chick requirements on a metabolic basis (Table 3) indicates 
that supply of all a-vitamins in pure ruminal fluid DM 
(except for thiamin) is in excess. Other researchers have 
occasionally observed very low concentrations of thiamin in 
ruminal contents despite the absence of clinical deficiency 
signs (Hunt et al., 1943: Phillipson and Reid, 1957: Hayes 
et al., 1966). These observations suggest that subclinical 
deficiencies of thiamin may depress performance without 
inevitably leading to polioencephalomalacia. 
Average daily gain (ADG), dry matter intake (DMI), feed 
efficiency (G/F) and survival of the chicks fed various 
diets are presented in Table 4. Despite the objectionable 
odor of ruminal contents, adding ruminal contents to the 
vitamin-free diets increased (P < .05) DMI with six of the 
eight single vitamin-deficient diets, as well as with the 
COMPLETE and DEVOID diets. Addition of ruminal contents 
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Table 3. B-vitamin composition of ruminal contents compared 

























Chick supplied by 
requirementa rumen contents 

















aRequirements for chicks o to3 weeks of age (NRC, 
1984). 
Table 4. Chick average daily gain, dry matter intake, 











feed % to end 
Complete + 
Complete 


























































• 607b 100 
• 659c 97 
. 601b 97 
• 672C 97 
. 578b 100 
. 624b 95 
. 549b 100 
. 654b 97 
. 586b 97 
• 407c 100 
. 582b 87 
.469c 93 
. 491b 97a 
• 257c 20b 
. 004b 100 
• 093c 100 
-.086 96 
-. 209 94 
. 448 100a 
• 341 13b 
aThe vitamin treatment describes the B-vitamin that was 
omitted from the diet; + indicates that ruminal contents 
were mixed with the diet whereas - indicates the diet had 
no ruminal contents added. 
b,cMeans within a vitamin without a common superscript 
differ. 
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increased dry matter intake by 48%, 56%, 57%, 120%, 127%, 
150% and 178% for the folic acid, niacin, pantothenic acid, 
pyridoxine (vitamin a6), riboflavin, thiamin and the a-
vitamin devoid (DEVOID) diets, respectively. Chick DMI 
often is depressed when vitamins are deficient; therefore 
some of the increase in feed intake by chicks fed the RC+ 
vitamin-deficient diets probably was due to provision of the 
limiting a-vitamin(s) by the ruminal contents. However, dry 
matter intake also was increased by a mean of 43% for the 
RC+ COMPLETE diet compared to the dry (RC-) COMPLETE diet, 
indicating that other characteristics of the diets with 
ruminal fluid added increased intake even though dietary 
vitamin concentrations were adequate. 
For six of the eight vitamin-deficient diets tested, 
addition of ruminal contents numerically increased ADG or 
decreased weight loss. The improvement was significant for 
folic acid, riboflavin, pyridoxine, thiamin, pantothenic 
acid, and DEVOID diets. Therefore, ruminal contents 
presumably provided substantial amounts of these a-vitamins 
for growth in addition to stimulating dry matter intake. 
Alternatively, ruminal contents may have provided other 
nutrients which spared deficient vitamins or delayed the 
onset of a-vitamin deficiencies. 
The diet devoid of all a-vitamins (DEVOID) resulted in 
lower dry matter intake, ADG and survival compared to the 
diet supplemented with all a-vitamins (COMPLETE) confirming 
that the DEVOID diet was deficient in at least some of the 
B-vitamins tested. With chicks fed the DEVOID diet, mortal-
ity was first observed on day 8 and totalled 87.5% at the 
end of the trial. The most prevalent deficiency signs were 
similar to those for thiamin-deficient birds, specifically 
opisthotonus. Ruminal contents increased dry matter intake, 
ADG, G/F and survival for chicks fed the DEVOID diet, but 
failed to restore growth to that of the COMPLETE diet. 
Performance of chicks fed the RC- folic acid, niacin 
and choline-deficient diets was almost equal to that of 
chicks fed the RC- COMPLETE diet. For choline, a deficiency 
may be slow to develop or slow to affect growth. The 
severity of choline deficiency lesions is markedly affected 
by other dietary factors such as methionine, vitamin B12, 
and folic acid, the nature of dietary fat and protein, and 
the choline source (Chan, 1991). In birds, choline 
deficiency retards growth and induces perosis. Leg problems 
(perosis, short and thick legs, and thickened, red hocks) 
occurred in some birds on both RC+ and RC- choline- diets, 
but a choline deficiency had little effect on ADG or dry 
matter intake. 
Responses to addition of ruminal contents by chicks fed 
riboflavin and pyridoxine deficient diets were similar. 
ADG, DMI, and G/F were reduced on the RC- diets; both 
responded to the addition of ruminal contents. Performance 
on both RC+ diets was at least as good as on the RC-
COMPLETE diet. Leg problems, including curled toes and 
inability to stand, were common in the RC- riboflavin-
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birds, and probably reduced intake. Feathering was poor in 
the RC- pyridoxine- birds. Survival was not affected with 
either RC- diet, although dry matter intake was greatly 
reduced in the final few days of the experiment. 
Thiamin deficiency severely reduced performance even 
though the chicks gained weight during the first week. Dry 
matter intake increased for the first 4 days, then dropped 
to 5 grams or less from day 8 onward. Mortality began to 
occur on day 8. Birds were very weak and exhibited opistho-
tonus, a classic thiamin-deficiency sign also observed in 
thiamin-deficient cattle. Added rumina! contents improved 
(P < .05) ADG, DMI, G/F and survival. With ruminal 
contents, dry matter intake increased from days 1 to 6 of 
the study, and decreased from days 8 to 14, indicating that 
ruminal contents only partially met the chick's thiamin 
requirements. This might be expected because rumina! 
contents provided only 4.6% of estimated thiamin require-
ments (Table 3); nevertheless, it delayed the onset of 
deficiency symptoms. Polioencephalomalacia, a thiamin 
deficiency disease which can occur in feedlot cattle, has 
been associated with ruminal thiamin destruction or 
production of antimetabolites (Brent and Bartley, 1984; 
Harmeyer and Kollenkirchen, 1989). In this study, the low 
ruminal concentrations measured may have been related either 
to marginal synthesis or ruminal degradation. However, the 
positive chick response to ruminal contents indicates that 
antimetabolites were not a major problem. Chicks previously 
have been used to assess thiamin concentration of ruminal 
contents, resultinq in analyzed values of 2 to 12 ppm for 
ruminal dry matter (McElroy and Goss, 1939; Weqner et al, 
1940, 1941); those are much hiqher than the thiamin 
concentration in our study (.67 ppm). 
Performance was very poor for birds fed both the B12 
and pantothenic acid deficient diets; these birds were 
lively and appeared to be healthy. Feed intake was very 
low, hiqhly variable, and virtually ceased within a week. 
Ruminal contents added to the B12-deficient diet did not 
siqnificantly improve intake, in fact, added ruminal 
contents decreased (P < .05) ADG and G/F. Depressed ADG and 
G/F for RC+ compared to RC- suqqest that ruminal contents 
exacerbated the B12 deficiency, even thouqh survival was not 
depressed. Survival on both B12-deficient diets was hiqh; 
compared to other B-vitamins, s12 is retained tenaciously in 
the body. Also, reduced intake may be a mechanism to 
enhance survival. 
Accordinq to microbial analysis, ruminal contents from 
our steers contained 1.38 ppm B12 : therefore, ruminal 
contents should have provided 1900% of requirements for B12 
in the RC+ diet. However, rumen contents may contain 
several B12 analoqs, especially in cattle fed hiqh-qrain 
diets (Sutton and Elliot, 1972). Ruminal production of B12 
analoqs, e.q. pseudovitamin B12' Factor A, and Factor B, can 
exceed ruminal B12 synthesis (Biqqer et al., 1976). Natural 
vitamin s12 analoqs exhibit little or no activity in animals 
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even though they are active in microbial systems (Elliot, 
1980). Consequently, they may be incorrectly identified as 
B12 by the microbial B12 assay. Whether B12 analogs are 
detrimental to ruminants is not known. 
Birds fed pantothenate-deficient diets, with or without 
rumina! contents, had low dry matter intakes and lost weight 
although survival was quite high. Added rumina! contents 
increased dry matter intake and G/F, and decreased weight 
loss. However, even though rumina! contents contributed 
38.6% of pantothenic acid requirements, dry matter intake, 
ADG and feed efficiency were much poorer for both RC+ and 
RC- diets than for any other diets, even though mortality 
was considerably higher in the RC-thiamin- and RC-DEVOID 
diets. The RC+ pantothenate-deficient diet was the only RC+ 
diet that resulted in weight loss, perhaps due to the a12 
analogs in rumina! contents, as a12 supply may be important 
in pantothenic acid deficiency. a 12 has a sparing action on 
pantothenic acid requirements in poultry (Yacowitz, 1951). 
Other nutritional interactions also may be important. 
Pantothenic acid requirements are influenced by dietary 
concentrations of biotin, ascorbic acid, folic acid, fat, 
protein and copper (Fox, 1991). 
Another possible reason for the inability of panto-
thenic acid from rumina! contents to better meet chick 
requirements could be due to destruction of pantothenic acid 
during and after mixing rumina! contents with the dry feed. 
Pantothenic acid is one of the least stable a-vitamins. It 
must be stabilized for use as a feed additive by conversion 
into the calcium salt. Finlayson and Seeley (1983) measured 
"total", Coenzyme A-bound pantothenate, and free pantothenic 
acid in rumina! contents, using a LaCtobacillus plantarum 
assay. Total pantothenic acid flow to the duodenum ranged 
from 11.4 to 39.6 mgjday for 50 kg sheep fed 9 diets. Most 
of the pantothenate (9.6 to 34.5 mgjday) was in the form of 
Coenzyme A; the coenzyme should be more stable than free 
pantothenic acid. However, pH and heat are known to affect 
stability of rumina! pantothenate. Wegner et al. (1943) 
used a microbiological assay to analyze pantothenic acid in 
rumina! contents from a heifer. When a sample was split and 
dried at 40 to sooc without acid or after adjusting pH to 
4.7, the original sample assayed at 24.4 ppm compared to 
only 8.0 ppm for the acid-treated sample. Because the chick 
diet was slightly acidic due to the inclusion of 1% citric 
acid, this may have increased destruction of pantothenic 
acid. Further investigation is needed to determine if the 
growth-depressing effect of rumina! fluid as a pantothenic 
acid source was due to low availability or degradation of 
the vitamin after mixing with the dry diet. 
conclusions 
A 14-day chick bioassay was used in which chicks were 
fed vitamin-deficient diets in order to assess the 
availability/supply of rumina! a-vitamins. The test was 
insensitive for folic acid, niacin and choline; dry matter 
intake, ADG and feed efficiency were not depressed by these 
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deficiencies under the conditions of this study. Single 
deficiencies of thiamin, riboflavin, vitamin s6 and 
pantothenic acid reduced dry matter intake, ADG, and feed 
efficiency. Addition of ruminal contents increased ADG or 
dry matter intake for chicks fed these vitamin deficient 
diets. According to microbial analysis, ruminal contents 
provided 62.0%, 19.8%, 4.6% and 38.6% of the chick require-
ments for riboflavin, pyridoxine, thiamin and pantothenic 
acid. However, growth response to pantothenate in ruminal 
contents was very low. 
In contrast, no benefit from added ruminal contents was 
evident with the B12-deficient diet. By microbial assay, 
ruminal contents provided 1900% of the chick's requirements 
for this vitamin. True B12 may have been only a small 
fraction of the analyzed B12 content. Depression of growth 
from addition of rumen contents to the B12 deficient diet 
suggests that B12 adequacy may be marginal for cattle fed 
concentrate diets due to low availability or presence of 
analogs. Also, the low thiamin concentration in ruminal 
contents indicates that the supply of thiamin may be 
inadequate for rapid growth. 
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CHAPTER IV 
BLOOD PLASMA LEVElS OF B-VITAMINS IN DIFFERENT 
CLASSES OF CATTLE 
P. L. Dubeski, F. N. owens and w. o. Song 
ABSTRACT 
Blood plasma samples from suckling beef calves, dairy cows, 
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feedlot cattle, and stressed weaned calves were analyzed for 
vitamin c, folic acid, pantothenic acid, and vitamin B12 • 
The B6 vitamers also were analyzed in blood plasma samples 
from one group of stressed calves. Differences in blood 
plasma vitamin levels were detected between groups. Plasma 
vitamin c was highest in suckling calves, but similar for 
dairy cows, feedlot cattle and stressed calves. The lowest 
vitamin c concentrations were found in stressed calves and 
dairy cows; these would be considered deficient based on 
standards for humans. Plasma folic acid levels were highest 
in feedlot cattle and lowest in suckling calves. Vitamin 
B12 plasma levels were similar to levels in humans, except 
for feedlot cattle, some of which would be considered 
deficient based on guidelines for humans. Low B12 in plasma 
of feedlot cattle reflects the high rumina! production of 
B12 analogs when cattle are fed high concentrate diets. In 
the radioassay for B12 we used, purified intrinsic factor 
served as the binding protein; therefore, we measured only 
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B12· Many previous assays have included inactive s12 
analogs together with B12' resulting in higher plasma 
levels. Using a highly sensitive technique for measurement 
of blood plasma pantothenic acid, concentrations were found 
to be markedly lower than in plasma from humans or rats. 
Plasma pantothenate was higher (P < .05) in feedlot cattle 
and suckling calves than in stressed calves and dairy cows. 
Pyridoxal phosphate and total B6 concentrations in stressed 
calves were extremely low compared to values published for a 
limited number of healthy calves. 
(Key Words: B-Vitamins, Stress, Vitamin c, Folic, 
Pantothenic, B12·> 
Xntroduotion 
Microbial synthesis of B-vitamins generally has been 
considered sufficient to meet requirements for cattle. 
However, production responses to various supplemental 
dietary B-vitamins have been demonstrated in several classes 
of cattle. For example, niacin supplementation of dairy 
cows in early lactation has alleviated ketosis (Fronk and 
Schultz, 1979) and increased milk production (Muller et al., 
1986). Niacin has improved performance of cattle fed some 
growing and finishing diets (Byers, 1981). Thiamin is used 
therapeutically to treat polioencephalomalacia in cattle 
(Thomas, 1986), and also frequently is added in combination 
with niacin to diets for starting calves. Stressed, sick or 
anorexic calves often are injected with commercial B-vitamin 
mixtures, though the popularity of this practice has 
declined recently due to the current focus on injection-site 
lesions. Formulas for injectable B-vitamin complexes are 
not based on any research findings. 
In the absence of data on blood or tissue B-vitamin 
levels, it is difficult to determine whether responses to 
dietary supplementation can be ascribed to changes in post-
rumina! vitamin flow or alterations in ruminal fermentation. 
Assessment of blood B-vitamin levels should allow one to 
evaluate B-vitamin status and, hence, the effectiveness of 
supplementation strategies. Data establishing normal plasma 
levels of B-vitamins in cattle are needed in order to detect 
responses to an increase in the supply and to determine when 
cattle might benefit from supplementation. 
In this study, blood plasma samples were obtained from 
dairy cows, feedlot cattle, suckling beef calves, and three 
truck-loads of tranport-stressed calves. We measured plasma 
concentrations of B-vitamins in these different classes of 
cattle, focussing on B-vitamins critical to the immune 
response of stressed cattle, i.e., vitamin s 6 , folic acid, 
vitamin C and pantothenic acid. Vitamin B12 also was 
measured. Our objective was to develop baseline and 
comparative data on the mean and the range of blood plasma 
concentrations of these B-vitamins in specific classes of 
cattle. These may prove useful for evaluating B-vitamin 
status by 1) comparison with the nonruminant literature and 
2) comparison with other classes of cattle. 
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Kateriala and Methods 
Animals. Suckling calves from 2 crossbred beef cattle herds 
on native range, two groups of high-producing dairy cows, 
feedlot cattle, and three groups of stressed calves were 
sampled. Numbers and description are provided in Table 5. 
Blood samples. Blood samples were collected by jugular 
venipuncture in 10 ml evacuated glass tubes (Vacutainer, 
Sherwood Medical, st. Louis, MO). For each animal sampled, 
three tubes were collected with potassium EDTA as an 
anticoagulant and two tubes with sodium heparin as an 
anticoagulant. 
Vitamin Assays. Multiple samples of plasma were frozen at -
20°C in appropriate aliquots for subsequent analysis of the 
water soluble vitamins. Samples were processed under 
subdued lighting to minimize photodegradation; this is a 
problem primarily with the B6 vitamers and vitamin c. 
Heparinized plasma for vitamin C analysis was added 1:1 to 
10% (wjv) metaphosphoric acid prepared immediately before 
use; dilution was lower than the 1:5 with 6% metaphosphoric 
acid that is used for human plasma due to lower 
concentrations of vitamin C in livestock plasma. These 
samples were vortexed and frozen immediately. 
Vitamin c in heparinized plasma was measured 
colorimetrically using derivitization with 2,4-
dinitrophenylhydrazine (McCormick, 1986). Ascorbic acid was 
oxidized by CU(II) to form dehydroascorbic acid; this reacts 
with acidic 2,4-dinitrophenylhydrazine to form a red bis-
Table 5. Description of cattle used in B-vitamin survey 
Class 














Fallborn British x Limousin steer calves, 6-8 
months, 225 kg, dormant native range, 4/8/91 
Fall born Angus/Hereford steer calves, 6-8 
months, 190 kg, separated from dams 20 h before 
sampling, dormant winter range, 3/27/91 
osu Holsteins, average 7-day production 36 kg 
osu Holsteins, average 7-day production 36.7 kg, 
(range 28.1 - 52.0) 
Mixed crossbred steers, 475 kg, corn-based 
finishing diet 
Mixed crossbred heifers, Arkansas, 218 kg 
Mixed crossbred heifers, Missouri, 186 kg 
Mixed crossbred heifers, Georgia, 195 kg 
"' 00 
hydrazone which was measured at 520 ~. In order to 
minimize reaction of the 2,4-dinitrophenylhydrazine with 
aldehydes or ketones in the sample (e.g., glucose, pyruvate) 
a 40 hour incubation period at 15 to 18 oc was used instead 
of the more usual 3 to 4 h at 37 oc; at low temperatures 
coupling is much faster with dehydroascorbic acid than with 
other compounds. This also allows more complete reaction of 
the dehydroascorbic acid (E. Norkus, Our Lady of Mercy 
Medical Center, Bronx, Personal Communication, 1991). Using 
thiourea increases the specificity (Strohecker and Henning, 
1965; Roe, 1967), and incubating for 1/2 hour after addition 
of the H2S04 also helps destroy non-specific binding 
(Pelletier, 1985). 
Folate and vitamin B12 plasma concentrations were 
measured in K2EDTA plasma using a radioassay method for 
human samples (Quantaphase Folate and Vitamin B12 
Radioassay, Bio-Rad Clinical Division, Hercules, 
California); this had been validated for folate quantitation 
in bovine blood samples by Girard et al. (1989). 
Pantothenic acid in heparinized plasma was measured 
using a sensitive indirect ELISA assay (Song et al., 1990) 
at Dr. Song's laboratory at Michigan State University. The 
antibody is not available commercially; it is prepared in 
rabbits by immunization with pantothenic acid conjugated to 
bovine serum albumin. Each sample was assayed by two 
technicians, and results were averaged. 
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The B6 vitamers were analyzed in heparinized plasma 
using a cation-exchange HPLC procedure (Coburn and Mahuren, 
1983) at Dr. Coburn's laboratory in the Fort Wayne State 
Development Center. Plasma, treated with trichloroacetic 
acid to remove protein and free protein-bound forms, was 
extracted with redistilled ethyl ether. The aqueous 
portion, filtered through a .45 ~ membrane, was mixed just 
prior to injection with an internal standard (2-amino-5-
chlorobenzoic acid). Post-column injection of a phosphate 
buffer containing bisulfite permitted all seven major forms 
of vitamin s6 to be detected with good sensitivity at a 
single wavelength (Coburn and Mahuren, 1983). 
An ion-exchange HPLC method for simultaneous detection 
of thiamin, riboflavin and the B6 vitamers previously used 
for human blood plasma was evaluated for use with bovine 
plasma samples (Botticher and Botticher, 1987). This 
procedure was not useful as the very low thiamin and 
riboflavin concentrations in plasma could not be detected 
with uv detection. Also, the procedure involved use of the 
multi-enzyme mixture Clara Diastase to release protein and 
degrade the phosphate ester linkage; the enzyme is difficult 
to obtain, frequently contaminated with B-vitamins of 
interest, and produced an extremely high background when 
incubated with bovine plasma. However, vitamin B6 could be 
detected when the procedure was modified using potato acid 
phosphatase instead of Clara Diastase. The C18 solid phase 
extraction columns in this technique was very useful in 
sample cleanup, and may improve sample cleanup for some a-
vitamins in other HPLC techniques. However, the method 
provides less information for the B6 vitamers than other 
procedures (Coburn and Mahuren, 1983) which allow separate 
detection of each B6 vitamer. 
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Statistical Analysis. Plasma vitamin data were analyzed by 
analysis of variance models testing the effect of animal 
class. Means were separated using Duncan's Multiple Range 
Test. 
Results 
Blood plasma vitamin concentrations are shown in Table 
6 and Table 7. Plasma ascorbic acid, folic acid, vitamin 
s12 and pantothenic acid concentrations were affected by 
class of cattle (P < .001). 
Plasma ascorbic acid was higher (P < .05) in suckling 
calves than in feedlot cattle, stressed weaned calves, and 
dairy cows (1.04 vs .49, .44, and .42 mg/dL: P < .05). 
Plasma folate averaged 26.0, 13.1, 9.7 and 6.8 ngjml in 
feedlot cattle, dairy cattle, stressed calves and suckling 
calves, respectively. 
Vitamin s12 concentrations in plasma were similar in 
suckling calves, stressed calves and dairy cows (229, 251, 
and 286 pgjml respectively). However, plasma from feedlot 
cattle was lower in vitamin B12 (160 pg/ml; P < .05). 
Plasma pantothenic acid concentrations were similar (P 
> .05) in feedlot cattle and suckling calves, averaging 
0.143 and 0.128 nm/mL, respectively. Concentrations were 
Table 6. Plasma vitamin levels in cattle 
Class of Cattle 
Vitamin Item Beef Calf Stressed Calf Feedlot Dairy cows SE 
Vitamin c n 35 41 16 44 
(mg/dL) mean 1.04a .44b .49b .42b .09 
range .54-2.12 .22-.76 .34-.83 .13-.76 
Folic Acid n 35 13 14 31 
(ngfmL) mean 6.8d 9.7c 26.oa 13.1b 1.7 
range 3.2-11.0 6.4-14.6 14.2-35.2 7.1-25.4 
Vitamin B12 n 34 13 14 
(pg/mL) mean 229a 251a 16ob 
17 
286a 35 
range 113-277 116-396 97-297 150-396 
Pantothenic Acid n 31 25 16 14 
(nmfmL) mean .128a .o95b .143a .089b .019 
range .039-.195 .027-.167 .062-.201 .023-.186 




Table 7. Plasma B6 vitamers in stressed calves 
Vitamer (nM) 
Animal PLP PL 4PA PN Total B6 
1 101 9 35 ND 145 
2 46 ND 43 ND 89 
3 95 ND 27 ND 122 
4 64 ND 39 ND 103 
5 74 6 33 ND 113 
6 147 ND 31 ND 178 
7 148 8 31 ND 187 
8 102 ND 28 ND 130 
9 222 47 37 62 368 
Mean a 97 2.9 33.4 0 133 
SEa 37 4.1 5.4 0 35 
aincludes data from animals 1 to 8, omitting 9, which may 
have been recently injected with pyridoxine. 
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similar (P > .05) for stressed calves and dairy cows, (0.095 
and 0.089 nmjmL respectively), but were lower than values 
for feedlot cattle and suckling calves (P < .05). 
Plasma pyridoxal phosphate (PLP) averaged 97 nM in a 
group of eight stressed calves (Table 7). Pyridoxal (PL) 
averaged 2.9 nM in these calves. The B6 metabolite, 4-
pyridoxic acid (4PA), averaged 33.4 nM. No pyridoxine (PN) 
was detected in plasma from these calves. Data from animal 
9 was not used to calculate means and standard errors for 
the B6 vitamers, because high PLP, total BG, and presence of 
pyridoxine in its serum suggest it may have been injected 
with pyridoxine. Plasma from animal 9 contained 62 nM 
pyridoxine. Total B6 averaged 133 nM in the eight stressed 
calves when 4PA was included. However, some researchers do 
not include 4PA in the total plasma B6, because it is not 
available. 
Discussion 
Ascorbic Acid. Numerous methods can be used to measure 
either total ascorbic acid, or ascorbic acid, 
dehydroascorbic acid, and 2,3-diketogulonic acid. Common 
methods include chemical, electrochemical, and 
chromatographic (ion-exchange, ion-pair, and partition) 
procedures. 
Ascorbic acid is easily and reversibly oxidized to 
dehydroascor~ic acid, a compound which is less stable but 
still physiologically active. Dehydroascorbic acid is 
irreversibly oxidized to 2,3-diketogulonic acid; this acid 
has no ascorbic acid activity and can be further cleaved or 
excreted intact. Ascorbic acid in serum is rapidly deqraded 
at room temperature, but it can be stored for 3 weeks at -70 
°C without a preservative, or at -10 to -15 oc when mixed 
with a metaphosphoric acid solution (Pelletier, 1985). In 
animals, ascorbic acid normally occurs entirely or nearly 
entirely in its reduced form; animal tissues contain systems 
to reduce dehydroascorbic acid to ascorbic acid. Therefore, 
it is assumed that values obtained by the dinitrophenyl-
hydrazine method are entirely ascorbic acid (Roe, 1953). 
Whole blood, serum, and plasma concentrations are used 
as biochemical indicators of ascorbic acid status. Human 
blood or plasma levels reflect recent intake, whereas 
peripheral blood leukocyte levels reflect tissue reserves. 
In humans, plasma ascorbic acid levels normally ranqe from 
.8 to 1.4 mq/dL (Jaffe, 1984). Plasma levels lower then .3 
mq/dL are considered deficient (Sauberlich, 1984). 
Diet is not an important source of ascorbic acid for 
ruminants. Dietary ascorbic acid is rapidly deqraded in the 
rumen. Cows• milk contains low levels of ascorbic acid, 
e.q., 1 to 2 mq/100 qrams; human babies develop scurvy when 
fed solely cows• milk because it contains less ascorbic acid 
than human breast milk (Moser and Bendich, 1991). However, 
a beef calf consuminq 5 kq milk/day would receive so to 100 
mq ascorbic acid daily; milk could contribute substantially 
to its ascorbic acid balance because milk can bypass the 
rumen. Cattle, unlike humans, possess a key enzyme for 
ascorbic acid synthesis, L-gulonolactone oxidase (GLO, EC 
1.1.3.8) in their liver. 
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The reason for the higher ascorbic acid concentration 
in suckling calves than other classes of cattle is not 
clear. It may reflect higher blood glucose levels in these 
animals. Compared to other classes of cattle, calves are 
more similar to nonruminants. Plasma concentrations in 
suckling calves ranged from .54 to 2.12 mg/dL; compared to 
normal concentrations in humans, none of these calves would 
be considered deficient in ascorbic acid. 
Ascorbic acid may be released from the liver and 
adrenals during stress, including procedures such as blood 
sampling; therefore, cattle unaccustomed to handling 
temporarily may have elevated blood ascorbic acid levels due 
to sampling. However, no clear correlation between plasma 
ascorbic acid and ease of sampling either within a class of 
cattle or between classes was evident. The group of 22 
calves that were handled most easily had higher ascorbic 
acid levels than calves that had been separated from their 
dams for 20 hours and were very difficult to sample (Table 
5) • 
Mean ascorbic acid levels were similar in the stressed 
calves, feedlot cattle and dairy cows, but all these classes 
had lower ascorbic acid concentrations than suckling calves 
and normal humans. Of the stressed calves and high-
producing dairy cows, 20 and 14 percent would be considered 
deficient based on human standards. If a plasma ascorbate 
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concentration <.40 mg/dL is considered to indicate a 
marginal deficiency, another 27% of stressed calves and 30% 
of lactating dairy cows are also at risk. Both dairy cows 
in early lactation and stressed calves should have been in 
negative energy balance for some period of time prior to 
sampling. Possibly the low plasma levels in some animals in 
these two classes could reflect a negative energy balance 
because D-glucose is the initial precursor for ascorbic 
acid. Alternatively, lower levels may reflect increased 
requirements in these animals due to production or physical 
stress. 
Folic acid, the common name for the commercial form of 
the vitamin, does not exist alone in nature. Folic acid 
(pteGlu) is composed of a pteridine linked through a 
methylene group at the C-6 position to a p-aminobenzoyl 
glutamate group. The naturally-occurring folates include 
over 100 structurally related compounds; they all are 
pteroyloligo-y-L-glutamates (pteGlun), where n indicates a 
chain of one to nine glutamates. 
Serum and plasma folate levels have been used exten-
sively to assess folate status in humans. Conveniently, 
serum contains only one major folate, 5-Methyl-H4pteGlu, the 
transport form of the vitamin: therefore concentrations 
reflect recent dietary intake in humans. In contrast, red 
cell folate reflects body stores at the time the red cell 
was formed; thereby, erythrocyte folate may be a more 
accurate, less variable index of folate status in humans 
(Brody, 1991). Folate levels are much higher in red cells; 
hemolysis must be avoided if plasma or serum is analyzed. 
Although much of the serum folate is nonspecifically bound, 
it can be analyzed without extraction, indicating that the 
pteridine moiety is sterically available to participate in 
other reactions (Rothenberg et al., 1975). 
The radioassay method used in this study is one of many 
techniques available which utilize a natural specific binder 
of folate which occurs in milk. Radioassays that use 
competitive protein-binding are simpler than microbiological 
assaus and are not affected by antibiotics. Serum folate 
levels may vary depending on the assay method or radioassay 
kit used; therefore, normal levels need to be established 
for each laboratory. 
In humans, serum folate levels of less than 3.0 ng/mL 
are considered deficient (high risk), levels between 3.0 and 
5.9 ng/dL are low (medium risk), and levels> 6.0 are 
considered acceptable. Folate and B12 frequently are 
measured simultaneously in human medicine. In a primary 
vitamin s12 deficiency, serum folate can be elevated while 
red cell levels are depressed. In a folic acid deficiency, 
both serum and red cell folate levels are depressed 
(Sauberlich, 1975). 
Ruminal bypass of dietary folate appeared negligible 
according to Zinn et al. (1987); this suggests that folic 
acid status of cattle is dependent solely on ruminal 
microbial synthesis. They also estimated that net microbial 
synthesis of folate was .42 mgjkg total tract digestible 
organic matter. Total duodenal flow of folate was estimated 
at 1.1 to 1.2 mgjday in 200 kg steers: this is very low 
compared to estimated requirements of 10 mgjday extrapolated 
from swine requirements. By comparison, Hayes et al. (1966) 
measured folate levels ranging from .080 to .186 mgjliter 
ruminal fluid, which, with a ruminal volume of 40 1 and a 
.05/h dilution rate would yield 3.2 to 7.4 mg folic 
acid/day. 
Plasma folic acid levels in cattle in this study do not 
support the conclusions of Zinn et al. (1987) that folate is 
deficient. Indeed, blood plasma folate levels tended to be 
high, except for suckling calves, which were lower and more 
similar to typical levels in humans. Microbial synthesis 
appears to be a generous source of folic acid, The 
technique used by Zinn et al. (1987) may have underestimated 
total folate due to destruction of folate in samples during 
drying at 6soc. Folates in solution are sensitive to 
oxygen, light, and pH extremes (Brody, 1991). Bell (1974) 
suggested that samples containing labile vitamins such as 
folic acid should be homogenized in a blender and assayed 
immediately without drying or freeze-drying. 
Plasma folate was highest in the feedlot cattle, being 
twice as high as in dairy cattle. Similarly, Hayes et al. 
(1966) observed that folate concentration in ruminal fluid 
was twice as high for yearling feedlot steers fed all-
concentrate diets than for steers fed similar diets with 1.8 
kg alfalfa hay added. Folic acid in ruminal fluid was 
negatively correlated with rumen pH in that study. The 
folate status of dairy cows may be lower than that of 
feedlot cattle due either to higher forage concentration in 
the diet and higher rumen pH, or due a a higher folate 
requirement for milk production. Fresh bovine milk contains 
.os to .12 ~ folatejg wet wt compared to .08 ~g/g wet wt 
for raw ground chuck (Brody, 1991). At a daily production 
of 30 kg of milk, 1.5 to 3.6 mg would be secreted daily, 
values equal to half of daily ruminal production. 
The lower folate concentrations in plasma from stressed 
calves compared to feedlot and dairy cattle may be due to 
impaired ruminal synthesis due to low feed intake, and 
increased metabolism due to stress. 
Blood plasma folate levels were lowest in the suckling 
calves; some would be considered marginally deficient based 
on human standards. Although these suckling calves all were 
at the age to ruminate, milk still could form a sizeable 
part of their diet. Because milk is digested primarily 
post-ruminally and is a relatively poor source of folate, 
total folate supply may be marginal in suckling calves. In 
our study, mean plasma folate was 6.8 ngjmL; values ranged 
from 3.2 to 11.0 ngjmL for suckling calves. Similarly, 
Girard et al. (1989) found that mean serum folate was 8.2 
ng/mL in 2 week old dairy heifers fed whole milk and 
concentrates. Older heifers (120 days in age and fed 1 kg 
concentrate twice daily plus hay and silaqe) had a mean 
serum folate concentration of 14.8 nq/mL. 
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VitaaiD B12· Vitamin B12 deficiencies in ruminants are 
not apparent except when dietary cobalt is inadequate for 
ruminal B12 synthesis. Ruminant orqans, particularly liver, 
brain, kidney and heart, are excellent dietary s12 sources 
for man (Ellenboqen and cooper, 1991). Vitamin s12 is 
stored in these orqans. In man, turnover is very low, about 
.1% of body stores/day; hence, it can take years to deplete 
body stores durinq a vitamin B12 deficiency. 
Both microbioloqical and radioassay methods have been 
used to assess vitamin B12 status in humans. In microbi-
oloqical assays, the ability of cobalamins to stimulate 
qrowth is quantitated by turbidimetry or by measurinq carbon 
monoxide production. Specificity of the assay for s12 
depends on the orqanism used. Ochromonas malhamensis 
utilizes cobalamins almost exclusively, whereas E. coli, 
Lactobacillus leichmannii and Euglena gracilis are less 
specific and will also utilize corrins that are unavailable 
to mammalian species (Nexo and Olesen, 1982). Microbiol-
oqical methods have been replaced larqely by radioassays. 
Isotope dilution methods are easier, faster, more 
precise and have lower detection limits than microbioloqical 
methods. By this method, bound cobalamin is extracted from 
either serum, heparinized or EDTA plasma, converted to 
cyanocobalamin, and mixed with a known quantity of radio-
active cyanocobalamin. Endoqenous B12 in the sample or a 
standard competes with the radioactive B12 for bindinq with 
a cobalamin-binding protein. Since 1980, radioassay kits 
sold in the u.s. have used purified intrinsic factor as the 
bindinq protein. Historically, numerous bindinq proteins 
were used, including transcobalamin, saliva binder, and a 
chicken serum protein (Nexo and Olesen, 1982). These 
proteins have lower affinities for B12 than does intrinsic 
factor: lower affinity allows nonspecific binding to s12 
analogs. The purity of the intrinsic factor is important; 
less purified preparations contain proteins which can bind 
inactive B12 analogs in serum (Ellenbogen and Cooper, 1991). 
Because of these problems, caution must be used when 
interpreting earlier studies using earlier assay methods. A 
serum sample assayed at 95 pq B12;mL was tested in a U.K. 
quality control study. Participatinq laboratories 
determined levels ranginq from 50 to 730 pq B12/mL by micro-
bioloqical assays, and 50 to 1750 pg/mL usinq radioassays 
(England and Linnell, 1980). Hence, the reliability of 
commercial cobalamin assays still is contested (Ellenboqen 
and Cooper, 1991). 
Less information is available for normal blood B12 
levels in cattle than in sheep. Levels in sheep can be 
markedly higher than in cattle, so values may not be useful 
as a quideline for assessinq bovine B12 status. For 
example, serum B12 in cobalt-deficient lambs was 100 to 256 
pq/mL, compared to 982 to 1613 pq/mL in cobalt-supplemented 
lambs (Stebbings and Lewis, 1986). However, these workers 
used a nonspecific analytical method which may have measured 
B12 analogs as well as B12• In another study, serum s12 
levels in marginally cobalt-deficient lambs averaged 320 ± 
111 pg/mL (Millar and Lorentz, 1979). 
Plasma B12 levels averaged 70 pg/mL in cobalt-deficient 
steers fed diets containing .03 to .04 ppm cobalt, compared 
to 180 pg/mL in cattle supplemented with cobalt (Bentley et 
al., 1954). These workers used the L. leichmannii assay. 
Our results were similar to those of Bentley et al. 
(1954): plasma B12 levels in cattle were not high when 
compared to normal levels in humans. Standards for s12 
status in humans were established by Bio-Rad (Clinical 
Division, Hercules, CA) for their radioassay method using 
data from 283 healthy adults and 105 patients diagnosed as 
B12 deficient. Normal was defined as serum B12 >200, 
marginal as 160 to 200, and deficient as < 160 pg B12/mL. 
Using these standards, average concentrations in suckling 
calves, stressed calves, and dairy cattle were normal, 
whereas plasma vitamin B12 in feedlot cattle is low. 
Approximately 57% of feedlot cattle, 23% of suckling calves, 
38% of stressed calves and 6% of lactating dairy cows would 
be considered deficient based on human standards. 
Implications of this are not known. Cobalt levels in 
Oklahoma feeds have not been defined although cobalt is 
supplemented routinely throughout the us and Canada. 
Nonetheless, some of these differences may reflect the 
adequacy of the cobalt-supplementation programs. 
The mean plasma B12 concentration in feedlot cattle was 
160 pg/mL, indicating a borderline deficiency. The lowest 
plasma B12 concentration, 97 pg/mL, was observed in a 
feedlot steer. The lower plasma B12 in feedlot cattle may 
be related to B12 analog production on the high concentrate 
diet. For most diets, only 15 to 20% of the B12-related 
compounds produced in the rumen exhibit B12 activity in 
animals (Dryden and Hartman, 1971). Feeding dairy cows a 
high concentrate diet resulted in lower liver and milk B12 
in spite of higher total (nonspecific) B12 in serum (Walker 
and Elliot, 1972). In sheep, a high corn diet (60% corn, 
40% timothy) markedly reduced B12 but not analog production. 
Total serum B12 measured nonspecifically increased with 
dietary corn level, but actual B12 in serum decreased 
(Sutton and Elliot, 1972). Possibly analog production at 
the expense of a12 is even more extensive on a typical 
feedlot diet containing 80% or more concentrate. 
More research is needed to determine whether the low 
a12 levels in plasma are physiologically important. Also, 
cobalt concentration of the diets should have been measured. 
Performance responses to a12 injections by feedlot steers 
have been variable. 
Pantothenic Acid. Pantothenic acid is found primarily 
in the form of coenzyme A in red blood cells, and as free 
pantothenic acid in plasma. Red blood cell pantothenic acid 
concentrations are higher than in plasma; red blood cell 
concentrations also are more responsive to dietary 
pantothenic acid (Fox, 1991), but serum levels will respond 
to extreme differences in intake. 
As pantothenic acid deficiencies are not observed in 
humans except during severe malnutrition, the volume of 
research on assessment of pantothenic acid status is minimal 
compared to that for other vitamins. Pantothenic acid 
deficiencies have been described in numerous animal species 
fed deficient diets, including the preruminant calf 
(Sheppard and Johnson, 1957). However, parameters of normal 
pantothenic acid status have not been defined for livestock. 
Methods for assessment of pantothenic acid status in 
humans include radioimmunoassay (Wyse et al., 1979), gas 
chromatography-mass fraqmentography (Banno et al., 1990) and 
indirect enzyme linked immunosorbent assay {Song et al., 
1990) of blood, plasma or tissue. Microbiological methods 
also are used but are tedious and time consuming. Microbi-
ological and chick assays are useful in measuring levels in 
feedstuffs and foods. 
An extremely wide range of total pantothenic acid 
levels in tissue samples of normal individuals has been 
reported, e.g., 1.1 to 12 ~for whole blood. Difficulties 
in enzymatic hydrolysis of bound forms and use of enzyme 
preparations containing pantothenic acid can explain this 
variation. The liberation of pantothenic acid from coenzyme 
A requires three enzyme activities: pyrophosphatase, 
orthophosphatase, and a specific amidase, pantetheinase, 
which is not available commercially. Enzymatic methods used 
to liberate pantothenic acid often result in unacceptable 
levels of error, and frequently overestimate pantothenic 
acid levels (Wittwer et al., 1989). 
In order to avoid these problems, pantothenic acid was 
measured using the ELISA, which does not require enzymatic 
preparation and is more sensitive than other methods (Song 
et al., 1990). This method may be sensitive to short-term 
changes in animal pantothenic acid status. Marked 
depressions of plasma or serum pantothenic acid have been 
noted previously only for rats fed pantothenic acid 
deficient diets for at least 4 weeks (Reibel et al., 1982); 
in humans, plasma pantothenic acid may not sensitively 
reflect pantothenic acid intake (Song et al., 1985). 
However, when plasma pantothenic acid was measured using the 
ELISA in rats fed a pantothenic acid deficient diet, it was 
depressed as early as 1 1/2 weeks (0.86 ±0.31 vs 1.56 ± 0.28 
nM in deficient and control rats, respectively; Song et al., 
1990). 
Plasma pantothenic acid levels in cattle were found to 
be markedly lower than levels in rat or human plasma 
analyzed by the same technique in the same laboratory. 
Bovine plasma pantothenic acid concentrations have not been 
reported previously. Plasma levels in humans normally are 
about 1.0 nM. The mean plasma pantothenic acid for our 86 
cattle was 0.115 nM. 
Plasma pantothenic acid was affected (P < .002) by 
cattle class. It was highest (P < .05) in feedlot cattle 
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and suckling calves (0.143 and 0.128 nM), and lowest in 
dairy cows and transport-stressed calves (.089 and .095 nM). 
The higher levels in feedlot cattle may be explained by 
the observation that ruminal pantothenic acid production is 
maximal on high concentrate diets. Hayes et al. (1966) 
found that the pantothenic acid concentration in rumina! 
fluid was 242 and 354 ~g/100 mL for steers fed flaked and 
ground corn diets, respectively. Levels were intermediate 
when the corn diet was fed with ground hay, and lowest (65 
and 77 ~g/100 mL) for flaked and ground corn diets, 
respectively, when fed with long hay. Similarly, 
pantothenic acid concentration in rumen contents was nearly 
four times higher in sheep fed a diet containing 90% corn, 
10% soybean meal, than in sheep fed prairie hay (30.1 vs 8.3 
~g/g OM; Hollis et al., 1954). 
As was observed for ascorbic acid, the lowest 
individual pantothenic acid levels were found in the dairy 
cows and stressed calves. Possibly in cattle, as in other 
species, ascorbic acid and pantothenic acid metabolism are 
interrelated (Fox, 1991). Low levels in dairy cows may 
partly reflect higher requirements due to pregancy and 
production, as milk contains 36 mg pantothenic acid/kg DM. 
Also, rumina! synthesis is lower with mixed diets than high 
concentrate diets; synthesis appears to be inversely 
correlated with rumina! pH. Dairy cow diets contain more 
forage than do feedlot diets; 40 to 60% roughage is typical. 
The cows in this study were fed a total mixed diet which 
contained buffers. 
The low levels of plasma pantothenic acid in stressed 
calves may be due to both decreased supply and increased 
demand. Reduced intake and impaired ruminal function in 
stressed calves would depress ruminal pantothenic acid 
synthesis. Furthermore, pantothenic acid is important in 
adrenal function. Corticosteroid production by adrenal 
glands in rats is reduced by a pantothenic acid deficiency 
and increased by intramuscular pantothenic acid injection 
(Fox, 1991). This suggests that requirements may be 
increased by stress, which increases corticosteroid 
production. 
Vitamin B6. The concentration of vitamin B6, 
particularly pyridoxal phosphate (PLP), in plasma is one of 
the most commonly used indicators of vitamin B6 status. 
Considerable interspecies variation occurs in the 
concentration and distribution of the B6 vitamers in plasma 
(Coburn et al., 1984); there is little interspecies 
variation in vitamin s6 requirements. Other techniques used 
in human nutrition are not appropriate for use in animal 
studies. They include urinary excretion of 4-pyridoxic 
acid, urinary excretion of certain tryptophan metabolites 
after a tryptophan load, and in vitro amino-transferase 
activity in red blood cells before and after the addition of 
PLP (Linkswiler, 1967; Reynolds and Leklem, 1981). 
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The presence of pyridoxine and elevated concentrations 
is PLP, PL and total B6 in plasma of one stressed calf 
suggested that it had been injected recently with 
pyridoxine. Therefore, values for the other eight animals 
were averaged to obtain mean values for stressed calves. 
However, Coburn et.al. (1984) reported that mean plasma 
pyridoxine concentration was 50 ± 67 nM in 3 "normal" 
calves, so perhaps either pyridoxine is found naturally in 
cattle plasma or it is formed by interconversion from other 
B6 vitamers during the analytical procedure. 
Mean plasma PLP for the eight stressed calves was 97 
nM; this is extremely low compared to a mean of 402 nM in 3 
healthy, non-stressed calves previously found using the same 
HPLC technique in the same laboratory (Coburn et al., 1984). 
Pyridoxal, not detected in 5 out of 8 calves, averaged 2.9 
nM, compared to 96 ± 11 previously reported. The B6 
excretory product, 4-pyridoxic acid, also was lower in the 
stressed calves, averaging 33.4 nM compared to 91 ± 68 nM 
reported. Total a6 averaged 133.4 nM in the eight stressed 
calves, compared to 686 ± 311 nM reported by Coburn et al. 
(1984). 
our data suggest that vitamin B6 status was severely 
compromised in the transport-stressed calf. More 
information on a6 vitamer concentration and distribution in 
plasma for various classes of cattle, including stressed 
calves, is needed. 
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CHAPTER V 
EFFECTS OF B-VITAMIN INJECTIONS ON BOVINE HERPESVIRUS-! 
INFECTION IN FEED-RESTRICTED WEANED BEEF CALVES 
P. L. Dubeski, J. M. d'Offay and F. N. OWens 
ABSTRACT 
Six-month-old beef steer calves were stressed to simulate 
the shipping/marketing cycle which may predispose calves to 
bovine respiratory disease. Stresses, which consisted of 
weaning, limit-feeding and fasting, were conducted in 
metabolism stalls. The calves lost 13.3% of initial weight 
between arrival and the end of a 3-day fast. At 20 days 
after arrival, the calves were inoculated intranasally with 
live attenuated bovine herpesvirus-! (BHV-1), a pathogen 
implicated in bovine respiratory disease. The calves were 
injected with B-vitamins and vitamin c on alternate days 
every second day for 2 weeks prior to and 2 weeks after 
virus inoculation. The stress/BHV-1 model resulted in a 
mild respiratory infection in all calves. B-vitamin 
injections did not significantly affect infection and 
immunity as measured by virus and interferon titers in nasal 
secretions, serum neutralizing antibody titers, and ability 
of lymphocytes to undergo blastogenesis in vitro when 
exposed to pokeweed mitogen. However, B-vitamin treatment 
increased serum IgG to aHV-1 (P< .OS) at 14 days post-
infection. 




The Bovine Respiratory Disease complex is responsible 
for approximately 75% of morbidity and mortality in feedlot 
cattle (Jensen et al., 1976), costing the cattle industry in 
the u.s. in excess of $500 million annually (McMillan, 
1983). The incidence is highest during the first 3 weeks 
after arrival, probably due to the impact of stresses during 
the shipping/marketing process which can compromise both 
immunity and the nutritional status of the animal. 
Nutrition of cattle prior to and after arrival at the 
feedlot has been shown to affect morbidity (Hutcheson and 
Cole, 1986). 
Requirements for some nutrients, particularly certain 
a-vitamins, are markedly affected by stress and disease 
(Mueller and Thomas, 1975). Specific a-vitamins (folic 
acid, pyridoxine, and pantothenic acid) are critical to the 
immune response, are not stored in the body, and can be 
rapidly depleted. 
The purpose of this study was to measure the effects of 
a-vitamin injections on immunity in nutritionally-stressed 
steer calves inoculated with bovine herpesvirus-1 (BHV-1). 
Infection with BHV-1 was used as a model for the bovine 
respiratory disease complex because it can cause a primary 
respiratory tract infection and predispose cattle to 
infection with Pasteurella (Yates, 1982). Further, BHV-1, 
producing only mild infections under laboratory conditions, 
is unlikely to cause mortality. 
Materials and Methods 
Bxperimental Procedure. During the first 20 days of the 
study, calves received a limited amount of feed and 
underwent a 3-day fast; this was an attempt to simulate the 
effects of shipping and handling on both nutritional status 
and rumina! function. The calves then were inoculated with 
BHV-1. All calves received a-vitamin or vehicle injections 
parentally every 48 hours for 2 weeks prior to and 2 weeks 
after BHV-1 inoculation. 
Calves. Seventeen Hereford X Angus crossbred 6 to 8 month 
old calves from one herd which had been wintered on dormant 
native range were weaned on April 23, 1991 (day -21). These 
calves previously had been tested for presence of antibodies 
to BHV-1; all were seronegative. They were trucked 10 miles 
to the Veterinary Medicine building, weighed on arrival, and 
housed individually in a room isolated from other cattle. 
Twelve steer calves were placed in elevated metabolism 
crates, whereas five steer and heifer calves (spares) were 
kept in slatted floor pens but otherwise treated 
identically. 
Diets. On arrival, each calf was fed .9 kq of native 
prairie grass hay (4% crude protein). From April 24 to May 
5, and May 9 to May 16, calves were offered this hay once 
daily at 1% of body weiqht (Table 8). All calves were 
fasted May 6, 7, and 8, (days -8, -7, and -6). On May 17 
(day 3), the feeding rate was adjusted to 1.5% of initial 
body weiqht so that calves would maintain their body weiqht. 
Because of the very low protein concentration (4% CP) in 
prairie hay, alfalfa hay (21% CP) was substituted for half 
of the prairie hay durinq the final week of the study. 
Treatments. The calves were assigned randomly to two 
treatment groups (Control, +Vit) with 6 calves in metabolism 
stalls per treatment. Additionally, three of the spare 
calves received the control treatment and two received the 
+Vit treatment. Each control calf received sterile saline 
injections. Each +Vit calf received injections of a-
vitamins and vitamin c (Table 9). These mixtures were 
custom formulated (American Veterinary Products, Fort 
Collins, Colorado). The injection treatments were imposed 
every 2nd day from 10 days after arrival (day -11) until the 
end of the ·experiment 31 days later. The parenteral route 
was selected for vitamin administration; had these vitamins 
been provided via either the water, the diet or a bolus, 
they would be subjected to either ruminal destruction 
and(or) variable intake. 
Weiqbt an4 Health. Body weiqht was recorded before feeding 
each week, and before and after the 3-day fast. Animals 
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Table 8. Daily feed intake (g/d)a,b 
Days 
Calf 
Treatment No. -20 -19to-9 -8to-6 -5to2 3to14 
Control 
3 1710 2300(1900)C 0 1900 2700 
5 1600 1600 0 1600 2200 
6 1180 1800 0 1800 2450 
8 1400 1400 0 1400 2100 
10 1600 1600 0 1600 2300 
11 1400 1400 0 1400 2000 
13 1600 1600(1500)C 0 1500 2200 
14 1200 1200 0 1200 1600 
17 1400 1400 0 1400 2000 
B-Vitamin 
1 1400 1400 0 1400 2000 
2 1800 1800 0 1800 2500 
4 1600 1600 0 1600 2300 
7 1300 1300 0 1300 1800 
9 1800 1800 0 1600 2300 
12 1600 1600 0 1600 2300 
15 1070 1400 0 1400 1900 
16 1500 1500 0 1500 2100 
aAs-fed basis (90% DM). 
bprairie hay (4% CP) was fed from day -20 to day; 50% 
priairie hay plus 50% alfalfa hay was fed from day 7 to day 
14. 
CFeed intakes adjusted on day -12 based on corrected 
animal weights. 




Vitamin Requirement a Factorb Dosagec 
Thiamin 6.76 mg 13.5 mg 
Riboflavin 16.91 mg 33.8 mg 
Niacin 67.64 mg 135.0 mg 
Folic acid 2.09 mg 15 60.0 mg 
Pantothenic acid 54.1 mg 2 216.0 mg 
Vitamin B6 6.76 mg 8 108.0 mg 
Vitamin a12 67.64 ug 2 270.0 ug 
Vitamin C Unknown 1000.0 mg 
aoaily B-vitamin requirements for a 190.5 kg calf were 
estimated on a metabolic body weight basis as equivalent 
to 3.56 times the requirements for a 34 kg pig (NRC, 
1990) . 
bThe estimated daily requirement was multiplied by 
factors of 2 for pantothenic acid and vitamin B12' 15 for 
folic acid, and 8 for vitamin B6 to account for the 
increased requirements of these specific B-vitamins 
during stress or "moderate" injury (Mueller and Thomas, 
1975). 
cTwice the daily estimated requirement was supplied by 
injection every 2 days, with one 3 ml dose containing the 
B-vitamins and one 4 ml dose containing the vitamin c. 
Controls received identical doses of sterile saline 
solution. 
were observed daily: rectal temperature of calves were 
measured at 0700 every day before feeding. 
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Blood samples. All blood samples were collected by jugular 
venipuncture in 10 ml evacuated tubes (Vacutainers, Sherwood 
Medical, St. Louis, MO). One blood sample was collected 
from each calf for serum neutralizing antibody titers on 
days 0, 7, 14, and 28. Blood for antibody measurement was 
allowed to clot: serum was harvested and heat inactivated 
(56oc for 30 minutes). Blood samples for lymphocyte 
blastogenesis were collected in Vacutainers with potassium 
EDTA shortly after arrival (day -15), and on days o, 5, 7 
and 14. Serum and plasma samples were stored at -2ooc until 
analyzed. 
Basal samples. Nasal secretions for interferon quantifi-
cation were collected on days o, 2, 4, 5, 7, and 9 by 
inserting tampons intranasally and removing them after 15 
minutes as discussed by McKercher (1973). Nasal swabs for 
virus quantification were collected on these same days. The 
swabs were immediately expressed into vials containing 3 ml 
of transport medium (on ice), and stored at -7o0 c until 
assayed (d 1 0ffay and Rosenquist, 1988). 
Viruses. The vaccine strain of BHV-1 (Nasalgen, Jensen-
Salsbery Laboratories, Kansas City, Mo.) in its second 
serial passage in this laboratory was used for animal 
inoculations (Todd et al., 1972). The Indiana strain of 
vesicular stomatitis virus (obtained from B. Easterday, 
University of Wisconsin, Madison) was used in plaque 
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reduction assays for IFN. Viruses were propagated by 
inoculating confluent MDBK cells with virus at a low 
multiplicity of infection. Infected cells were harvested by 
scraping when cytopathology indicated that at least 90 to 
100% of cells had been infected. 
Virus Xnoculation. on May 14 (day 0), the 12 test calves 
and one spare control calf were inoculated intranasally with 
107 plaque-forming units (PFU) of BHV-1 (vaccine strain) in 
1 ml of virus suspension, .5 mljnostril, with a syringe. 
Cell cultures. Madin Darby bovine kidney (MDBK) cell 
cultures were used for all assays, tests, and virus 
propagation. Growth medium for the MDBK cell cultures 
consisted of Eagle's minimal essential medium (MEM) in 
Earle's balanced salt solution supplemented with 5% fetal 
bovine serum (FBS), .075% NaHco3 , 10 mM HEPES buffer and 
antibiotics (penicillin 200 ~g/ml, streptomycin 200 ~gjml, 
fungizone .so ~g/ml). Maintenance medium was the same 
except that it also contained 2.5% FBS and 20 mM HEPES. 
Virus quantification. BHV-1 virus titers in nasal 
secretions were determined by plaque assay in 24-well tissue 
culture plates confluent with MDBK cells. Virus particles 
in different dilutions were quantitated in duplicate wells 
overlaid with 1% methylcellulose. 
Xnterferon assay. Nasal secretions, diluted 1:5 in MEM, 
dialyzed at 4oc overnight in pH 2.0 buffer and then in PBS 
(pH 7.2) for an additional 24 hours, were centrifuged at 
1500 X g for 20 minutes. Samples were screened at 1:20 
dilution, and, when necessary, diluted further to determine 
end points. Interferon was measured by a plaque-reduction 
assay with vesicular stomatitis virus as the challenqe-
exposure virus usinq 24-well tissue cultures plates 
confluent with MDBK cells (Fulton, 1986). Titers (median 
plaque-reduction unitsjml) were determined as described by 
d'Offay and Rosenquist (1986). 
Beutralization tests. Neutralizinq antibody titers in sera 
were determined by a microtiter serum neutralization test 
usinq 96-well tissue culture plates (Carbrey et al., 1972). 
Sera were diluted 2-fold and four wells were used per 
dilution. Approximately 100 PFU of BHV-1 were added to each 
well and the virus-serum mixture was incubated at 37oc for 
one hour. Trypsinized MDBK cells (approximately 75,000 
cellsjwell) then were added to each well. The plates were 
incubated at 37°C in 5% co2 atmosphere for 4 days and 
results were read. Antibody titers were recorded as the 
reciprocal of the hiqhest final sample dilution that 
completely protected at least 3 of 4 wells aqainst virus 
infection. 
ELISA Procedure. An ELISA was used to detect serum IqG 
antibody titers to BHV-1. Antiqen for the ELISA consisted 
of lysates of BHV-1 infected and non-infected MDBK cells. 
Round bottom 96-well polyvinyl plates (Dynatech Immulon 
II) were used for the assay. Wells were coated with 100 
~ljwell of either infected or control cell lysates and left 
overniqht at 4oc. The next morninq, the coatinq buffer was 
removed by inverting and blotting the plates. A blocking 
buffer consisting of 1% w;v bovine serum albumin in gelatin 
buffer (Gel-BSA) was added at 100 ~1/well, and the plates 
were incubated at 37°C for 1 hour. Buffer was removed and 
various dilutions of the primary antibody (serum samples) 
diluted in Gel-BSA were added to wells coated with antigen 
and to wells coated with uninfected (control) cell lysates. 
After incubation for 1 hour on a rotator at room 
temperature, wells were washed 5 times with phosphate-
buffered saline with Tween 20 (PBS-T). Then a secondary 
antibody consisting of rabbit anti-bovine IgG conjugated to 
peroxidase (Pel-Freez• Biologicals, Rogers, Arkansas) was 
added. After a 1 hour incubation period on the rotator at 
room temperature, wells were washed 5 times with PBS-T. A 
solution containing hydrogen peroxide and a-phenylenediamine 
dihydrochloride (OPD) was added (100 ~ljwell), and color was 
allowed to develop for 20-30 minutes. The reaction was 
stopped with 50 ~1 2M H2so4 and absorbance was measured at 
490 nm. Titers were expressed as the reciprocal of the 
highest dilution with an absorbancy index of at least 3. 
For a given dilution, the absorbancy index was the 
absorbancy (at 490 nm) in the antigen positive well divided 
by the absorbancy in the control well. 
Lymphocyte Blastogenesis Assay. Procedures of Wyckoff and 
Confer (1990) were followed. Ten ml samples of blood 
containing K2EDTA as an anticoagulant were kept at room 
temperature in the dark for up to one day before this assay 
1~ 
was performed. Peripheral blood mononuclear cells (PBMC) 
were obtained through density gradient centrifugation on a 
ficoll-sodium diatrozoate medium (Ficoll-Hypaque, Sigma 
Chemical Co., St. Louis, MO). The PBMC were removed with a 
pipette and washed three times with Hanks balanced salt 
solution (Gibco, Grand Island, NY). Lymphocytes were 
cultured in 96-well flat-bottomed microtiter plates 
(Corning, Cambridge, MA), with 5 X 105 cellsjwell in a total 
volume of .2 ml of Dulbecco•s Modified Eagles medium (DMEM) 
containing 10% fetal bovine ·serum, 2 mM L-glutamine, and so 
ugjml gentamycin. Stimulations were performed in 
quadruplicate with four concentrations (0, .25, .so, and 
1.00 ~g/ml) of pokeweed mitogen (PWM). The cultures were 
incubated in a humidified 10% co2 incubator for 5 days. On 
the final day, .025 ml of fresh DMEM containing 1.0 ~Ci [3H] 
thymidine (ICN, Irvine, CA) was added to each well. After 4 
hours, cultures were frozen at -7ooc. At the end of the 
study, cultures were harvested onto glass fiber filters and 
counted by scintillation spectroscopy (Model 300; Packard 
Instrument Co., Laguna Hills, CA). Lymphocyte 
transformation was expressed as a stimulation index (SI). 
The SI was calculated by dividing the mean cpm of sample 
wells by the mean cpm of non-stimulated control wells. 
statistical Analysis. Agglutination, viral replication, 
antibodies (neutralizing and ELISA), interferon, 
blastogenesis, weight and health data were analyzed by 
analysis of variance models using the main effects of 
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vitamin treatment and collection day. The effect of 
treatment was tested within each day using the animal within 
treatment mean square as the error term. 
Results 
Animal Observations. Weaning, handling, and 
experimental procedures did not clinically stress these 
calves. They readily adjusted to the metabolism crates, and 
within 1 to 2 days after arrival, they often remained at 
rest despite the presence of humans. Some were not even 
disturbed when rectal temperature was measured, preferring 
to remain resting instead of standing up during this 
procedure. 
a-vitamin and saline injections appeared to cause 
little discomfort, although vitamin c injections may have 
caused temporary discomfort. The lack of discomfort from 
the a-vitamin injection, in contrast to some commercial a-
vitamin injectable formulations, may be related to benzyl 
alcohol, an antibacterial preservative, present in 
commerical formulations but absent from our mixture. 
During the fasting period, activity was reduced and the 
calves drank <10% of normal water intake. Water intake 
typically is correlated positively with feed intake (NRC, 
1988). Removing water during the first day of the fast may 
not have been necessary to prevent water consumption because 
1~ 
when water was made available on the second day of the fast, 
the calves did not drink. 
Pee4 Intake. Hay was fed once daily at 0800 except on 
fast days. Feed intake is shown in Table 8. Feed 
consumption was consistent throughout the study. All feed 
was consumed within 2 hours of feeding except on day -20, 
when 3 calves did not consume all their feed before the next 
day. 
Calf Weight. On arrival, calf weight ranged from 121 
to 192 kg, with a mean weight of 165.2 kg (Table 10). 
Average calf weight did not differ (P > .OS) between 
treatments. During the first week after arrival, mean 
weight declined to 156.8 kg; body weight declined to 153.9 
kg the following week immediately before the fast period. 
Following the 3-day fast, average weight was 143.2 kg; 
calves lost a mean of 10.7 kg (7.0%) during the fast. Four 
days later, weight was 152.4 kg; body weight was 152.9 and 
153.9 kg the following weeks (on the maintenance feeding 
schedule). Total weight loss between day -21 and the end of 
the fast was 13.3% of initial weight; weight loss between 
day -21 and day o was 7.3% of initial weight. 
Rectal Temperature. Body temperature as measured by 
rectal temperature (RT) appeared to fluctuate from day to 
day (Appendix Table A). The mean RT usually was about .2soc 
lower for the +Vit cattle than for the control cattle. This 
appeared to be due to individual differences in RT which 
were apparent from the beginning of the study before vitamin 
Table 10. Effect of B-vitamin treatment on body weight of calves (kg) 
Day 
4/23 4/29 5/6 5/9 5/13 5/20 5/27 
Calf d -21 d -15 before end d 0 d 7 d 14 
Treatment No. In Wt fast fast BHV-1a 
Control 
3 192.3 187.3 184.6 173.3 180.5 181.9 182.3 
5 161.9 152.0 148.8 137.0 143.3 145.6 147.4 
6 182.8 169.6 167.4 156.9 162.4 165.1 168.3 
8 147.4 145.2 142.0 132.9 139.3 142.0 144.2 
10 166.0 158.8 157.9 146.1 153.8 156.0 156.5 
11 145.2 137.0 132.9 124.3 130.2 136.5 134.7 
13 158.3 154.2 150.1 140.2 149.7 150.6 149.7 
14 121.1 114.3 108.9 102.1 107.0 107.5 107.5 
Mean 166.1 158.4 155.7 145.2 154.4 154.7 155.7 
B-Vitamins 
1 146.5 137.9 133.8 126.1 132.0 133.4 136.1 
2 188.2 176.9 172.4 162.8 165.1 169.2 170.1 
4 165.6 158.8 155.6 - 14 5. 2 152.9 154.2 155.6 
7 130.6 122.9 122.5 108.9 117.0 122.9 124.7 
9 186.4 176.9 172.8 160.6 167.4 172.4 170.6 
12 167.8 156.5 155.1 142.9 150.1 154.2 154.7 
15 142.4 135.2 131.5 122.5 127.5 130.2 129.7 
16 152.9 151.5 144.2 132.4 137.9 141.1 139.7 
Mean 164.4 155.1 152.2 141.2 150.3 151.2 152.1 
Overall Mean 165.2 156.8 153.9 143.2 152.4 152.9 153.9 
s. E 8.5 8.1 8.0 7.9 7.7 7.5 7.3 




treatments were imposed. Therefore, the average of each 
animal's RT over the first 10 days of the study (before 
vitamin treatments began) was used as a covariate. a-
vitamin treatment, when covaried by mean RT from day -20 to 
day -11, did not significantly affect RT (P > .05) on any 
given day. 
Feed intake influenced RT. RT averaged 39oc during the 
first 3 days of the study. During the fasting period, RT 
declined consistently. On the day prior to the fast (d-9), 
RT averaged 38.7°C. During the 3 mornings of the fasting 
period, and the following morning before re-feeding, mean RT 
was 38.7, 38.4, 38.3, and 38.1oc, respectively. On the 
morning following re-feeding, temperature averaged 38.6oc. 
This indicates that RT is lower than normal in fasted 
calves: this may delay detection of infections. 
No fever was expected to develop in BHV-1 infected 
cattle until at least day 4 post-inoculation. Fever can be 
influenced by the strain of virus given, its dosage, and the 
immune status of the cattle. Two calves, #5 (Control) and 
#12 (+VIT) exhibited a fever on day 4 (Appendix Table A}. 
on day 5, only #12 had a fever, although #1,7,8, and 10 
appeared to have slightly elevated RT (RT>39.4°C). On day 
6, one calf, #8, had a fever, but no calves had a fever 
subsequently. Compared with previous rectal temperatures 
for each calf, tempera~ures post-infection were elevated in 
most calves for at least one day; however, no elevation in 
body temperature was detected in 3 of the calves on any day 
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after infection. Based on RT, this vaccine strain of BHV-1 
caused only a mild infection. 
Clinical Obaervationa. The BHV-1 infection caused mild 
respiratory disease in all of the calves; this appeared to 
be limited to the upper respiratory tract. Clinical signs 
of respiratory disease were noted on days 4 to 6 post-
infection. By day 4 and day 5, all calves developed a mild 
serous nasal discharge progressing to a mild mucopurulent 
discharge on day 5 in some of the calves. The nasal mucosa 
became inflamed with necrotic plaques observed in several 
calves. 
Excretion of BBV-1 virus. Prior to BHV-1 infection, no 
BHV-1 virus was recovered from the nasal secretions of the 
calves. For 9 days after inoculation, all calves, with the 
exception of calf #4 on day 9, excreted BHV-1 in their nasal 
secretions. Calf #4 excreted BHV-1 for at least 7 days, 
with no virus present in nasal secretions on day 9. In both 
treatment groups, mean viral shedding after inocu-lation was 
highest on day 4, but higher on day 7 than on day 5. (Table 
11). However, virus excretion in individual calves peaked 
at different times between day 2 and day 7. a-vitamin 
treatment did not affect (P > .05) mean daily virus 
excretion on any day. 
Neutralizing antibody titers. No neutralizing 
antibodies were detected in sera on days 0 and 7 post-
inoculation (Table 12). All calves seroconverted by day 28, 
with 11 out of 12 seroconverting by day 14. The exception 
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Table 11. Effect of B-vitamin treatment on BHV-1 titersa 
in infected calves 
Days 
Calf 
Treatment No. ob 2 4 5 7 9 
Control 
3 oc 3.5 5.3 5.4 5.4 4.0 
5 0 4.2 7.4 6.2 6.0 3.3 
6 0 4.5 6.6 5.5 6.0 3.3 
8 0 3.6 6.9 6.1 6.0 3.6 
10 0 6.1 5.7 5.6 6.0 2.3 
11 0 5.6 5.0 4.2 5.3 3.4 
Mean 0 4.58 6.15 5.50 5.78 3.32 
S.D. 0 1. 06 0.96 0.72 0.34 0.56 
B-Vitamins 
1 0 4.2 5.6 5.4 5.6 4.7 
2 0 5.6 7.4 6.7 6.0 4.3 
4 0 5.1 5.6 4.0 4.1 0.0 
7 0 5.2 6.9 6.5 6.5 2.6 
9 0 4.0 5.3 4.4 5.9 4.4 
Mean 0 4.92 6.05 5.17 5.61 3.15 
S.D. 0 0.66 0.87 1.22 0.81 1. 76 
Overall Mean 0 4.75 6.10 5.33 5.70 3.23 
S.E. 0 0.36 0.37 0.41 0.25 0.53 
aData expressed as BHV-1 titers (log10 PFU/ml). 
bAll calves were inoculated with 107 PFU BHV-1 on day 
o. 
co = No plaques in cultures inoculated with 0.5 ml of 
undiluted sample. 
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Table 12. Effect of B-vitamin treatment on serum 
neutralizing antibody titers in calves infected 
with bovine herpesvirus-Ia 
Days 
Calf 
Treatment No. ob 7 14 28 
Control 
3 oc 0 4 64 
5 0 0 8 8 
6 0 0 4 8 
8 0 0 8 32 
10 0 0 16 16 
11 0 0 8 8 
Mean 0 0 8.0 22.7 
S.D. 4.4 22.3 
B-Vitamins 
1 0 0 16 32 
2 0 0 16 16 
4 0 0 0 32 
7 0 0 8 64 
9 0 0 4 4 
12 0 0 16 16 
Mean 0 0 10.0 27.3 
S.D. 7.0 20.9 
Overall Mean 0 0 9.0 25.0 
S.E. 0 0 2.4 8.8 
aData expressed as the reciprocal of the serum 
dilution protecting at least 3 out of 4 wells from 100 
PFU BHV-1. 
bAll calves were inoculated with 107 PFU BHV-1. 
CTiter < 4 (not detectable) . 
was calf #4; it developed a high titer by day 28. Mean 
neutralizing antibody titers were somewhat higher for +Vit 
treatment compared to controls on days 14 and 28, but this 
difference was not significant (P >.SO). 
lU 
Interferon in nasal secretions. Interferon was 
detected in nasal secretions of 2 calves on day 2, and of 
all 13 calves on day 4 (Table 13). Interferon titers peaked 
on day 7, and dropped to very low levels on day 9. Peak IFN 
titers for individual calves averaged S640 for controls, and 
67SO for +Vit calves. IFN titers tended to be lower for 
+Vit calves on days 2 and 4, but higher on days s and 7. 
However, these treatment differences were not significant (P 
> .1S) on any day. 
Serum IgG titer to IBR virus. IgG titers to BHV-1 are 
shown in Table 14. The first IgG antibodies to BHV-1 were 
detected on day 14 and titers increased by day 28. IgG 
titers were 100 times higher on average than neutralizing 
antibody titers. However, for individual calves, the IgG 
and neutralizing antibody titers were highly correlated 
(r2=.90; P < .OS) on days 14 and 28. The mean IgG titer to 
BHV-1 was higher (P < .08) in +Vit calves than in control 
calves on day 14 (1120 versus S30). IgG titers were similar 
(P = 0.30) on day 28, with means of 2400 and 1870 for +Vit 
and control calves, respectively. Averaged across day 14 
and day 28, mean IgG titer for +Vit calves was 1760 compared 
to 1210 in controls (P = .13). 
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Table 13. Effect of B-vitamin treatment on IFN titersa in 




Treatment No. ob 2 4 5 7 9 
Control 
3 oc 0 740 0 0 0 
5 0 0 810 6200 5300 0 
6 0 0 10200 2700 9500 530 
8 0 0 3100 550 5100 210 
10 0 140 1900 4100 5100 250 
11 0 0 4500 1800 6500 0 
Mean 0 23 3540 2540 5250 165 
S.D. 0 57 3560 2320 3070 210 
B-Vitamins 
1 0 0 3500 620 830 50 
2 0 0 210 7700 20800 320 
4 0 0 1400 5500 4500 0 
7 0 110 1300 3300 8900 0 
9 0 0 150 560 1400 0 
12 0 0 400 0 200 460 
Mean 0 18 1160 2950 6100 140 
S.D. 0 45 1270 3100 7900 200 
Overall Mean 0 20.8 2350 2740 5680 152 
S.E. 0 2.9 1090 1125 2440 84 
aData expressed as interferon titers (Plaque 
Reduction50 unitsjmL). 
bAll calves were inoculated with 107 PFU BHV-1 on day 
o. 
co = Titer < 20. 
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Table 14. Effect of B-vitamin treatment on serum IgG 




Treatment No. ob 7 14 28 
Control 
3 oc 0 400 3200 
5 0 0 800 3200 
6 0 0 100 800 
8 0 0 400 1600 
10 0 0 800 1600 
11 0 0 800 800 
13 0 0 400 1600 
Trt Mean 0 0 53od 1830 
S.D. 255 930 
B-Vitamins 
1 0 0 1600 1600 
2 0 0 1600 3200 
4 0 0 100 3200 
7 0 0 1600 1600 
9 0 0 200 1600 
12 0 0 1600 3200 
Trt Mean 0 0 1120e 2400 
S.D. 680 800 
overall Mean 0 0 830 2130 
S.E. 230 400 
aigG titer expressed as reciprocal of the highest 
dilution with absorbancy index ~ 3. 
bAll calves were inoculated with 107 PFU BHV-1 on day 
o. 
co = Titer < 50. 
d,eMeans in the same column with different superscripts 
differ (P < .08). 
1~ 
Blast transforaation of lyaphocytea to pokeweed 
aitogan. The mean stimulation indices (SI), calculated as 
the mean index for the low, medium, and hiqh levels of 
mitoqen, are presented in Table 15. Variation within 
animals and sample periods was extremely hiqh for the 
lymphocyte blastoqenesis test: no clear trends were evident. 
Generally, stimulation indices were similar for all three 
levels of mitoqen, althouqh the hiqhest stimulation indices 
often were found with the hiqhest mitoqen level (Appendix 
table B). 
The SI was hiqher (P < .05) for the control calves in 
the initial samples taken 5 days after arrival (day -15), 
and on day 5 postinfection (440 and 1640 vs 210 and 250). 
Because the initial samples were taken on day -15, and a-
vitamin treatments did not beqin until day -11, the initial 
difference cannot be ascribed to vitamin injection. We 
attempted to adjust the model usinq initial SI as a 
covariate: this was not useful because the SI for individual 
calves varied drastically from period to period. 
Discussion 
The restricted feedinqjfastinq reqimen resulted in an 
averaqe shrink of 13.3% over the 16 day period from arrival 
to the end of the fast. Shrink normally refers to weiqht 
lost durinq transit. Lenqth of transport has been 
correlated with total shrink. Shrink by shippinq-stressed 
calves has been correlated with morbidity durinq the 
receivinq phase (Camp et al., 1983: Griffin, 1983). 
Table 15. Effect of B-vitamin treatment on lymphocyte 
blastogenesis. Mean stimulation indices 
Days 
Calf 
Treatment No. -15 oa 5 7 
Control 
3 346.7 25.7 1057.3 27.0 
5 464.0 172.0 1680.0 na 
6 767.7 40.0 3816.7 212.7 
8 271.7 103.7 348.3 19 ;3 
10 530.0 70.0 1108.0 558.3 
11 264.7 678.0 1838.0 316.3 
Mean 44o.8b 181.6 1641. 4b 226.7 
S.D. 191.7 248.8 1189.1 224.2 
B-Vitamin 
1 50.7 na 55.3 937.0 
·2 117.3 na 128.7 29.0 
4 269.3 na 251.3 27.7 
7 100.3 129.0 171.3 603.3 
9 405.7 425.7 520.0 492.3 
12 328.0 600.0 386.3 1229.0 
Mean 211. 9c 384.9 252.2c 553.1 
S.D. 142.6 238.1 173.4 481.9 
Overall Mean 326.0 249.3 946.8 404.7 
S.E. 69.0 117.4 346.9 158.8 
aAll calves were inoculated with 107 PFU BHV-1. 
b,cTreatment means in the same column with different 





















na = Little or no blastogenic response; data omitted from 
statistical analysis. 
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Transport causes weight loss in addition to that caused by 
the feed and water deprivation; both gastrointestinal tract 
contents and muscle tissue are lost. Digestive capacity is 
lost due to reduced rumina! volume, altered microbial 
populations, and impaired ruminal function (Koers et al., 
1974; Damron et al., 1979; Hamlett et al., 1983). As a 
result, appetite and intake recover slowly. Many calves do 
not eat for 5 or more days after being transported. 
The stress model used in this study, with a relatively 
long period of feed restriction an~ a 3-day fast after 
weaning, approximates some of the conditions undergone by 
shipping-stressed calves. Although total shrink over the 20 
days before virus inoculation (7.3%) was similar to that 
achieved in many cattle during a single haul, it was less 
severe than a shrink of more than 11% observed in highly 
stressed cattle (Griffin, 1983). 
In general, compared with stresses of commercial 
cattle, the stresses we imposed certainly were less acute 
(no long-distance trucking), fewer in number, and not 
imposed simultaneously. Cattle undergo additional stresses 
during the shipping/marketing process which are reimposed 
each time the cattle are sold or transported. These include 
psychological stresses (exposure to novel surroundings, 
feedstuffs, and cattle), as well as sorting, handling, 
loading, transport, crowding and physical discomfort due to 
fatigue, hunger, and thirst. As in humans, psychological 
stimuli (e.g., novel environments) are as effective as 
physical stimuli in elevating stress hormones in animals 
(Dantzer and Mormede, 1985). 
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Another important difference between our stress model 
and the shipping/marketing cycle involves duration of 
stress. In a traceback study of cattle from Kentucky, most 
animals were from different sources and most had been in 
transit for 8 to 9 weeks (D. G. Gill, Personal 
Communication, 1992). It is likely that many of those 
cattle had been resold throughout this period to buyers 
speculating on cattle and or attempting to assemble loads 
uniform in weight for sale to feedyards. Consequently, our 
prolonged period of nutritional restriction (20 days before 
aHV-1 inoculation) probably was shorter than typical. 
Fasting and reduced intake during the marketing cycle 
and after arrival presumably would affect the postruminal a-
vitamin supply, because the supply is positively correlated 
with feed intake (Zinn et al., 1987). However, if stress 
increases requirements and rate of depletion in stressed 
calves, our model may not have been adequate to reflect 
responses to injected a-vitamins in stressed calves. 
Clinical signs. The degree of fever and serous nasal 
discharges after viral inoculation were mild and similar to 
signs reported by others using the same strain of virus 
(Todd et al., 1972; d'Offay and Rosenquist, 1988). 
Rectal temperature. The observed day to day variation 
in rectal temperature of individual animals probably was 
normal because cattle do not control their body temperature 
closely but allow it to fluctuate diurnally in response to 
environmental temperatures. However, because our calves 
were kept indoors under fairly constant temperature 
conditions, environmental temperature changes should not 
have altered body temperature. 
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To minimize variation and simplify detection of 
elevated temperatures in sick calves, all temperatures were 
recorded early in the morning before any other activities 
began. Previous research has shown that temperature 
measurements are most accurate when taken in the early 
morning and when activity of the cattle is limited (Gill and 
Richey, 1982). 
We defined fever arbitrarily as an early morning rectal 
temperature above 40°C (104oF) (Dunbar et al., 1980; Janzen 
and McManus, 1980: Gill and Richey, 1982: Axe et al., 1984). 
This cut-off point has been found to be useful under feedlot 
conditions where animals must be moved and handled; movement 
and excitement tends to increase body temperature of cattle. 
Others have suggested that a fever could be defined as a 
rectal temperature over 39.4°C (10JOF) (Lofgreen et al., 
1975: Lofgreen et al., 1981): this might be more appropriate 
under the conditions of our study. 
Using the criterion of 4ooc, animal #10 had a fever 
(105.2F) on day o, the day that this animal was infected 
with BHV-1. We decided not to eliminate #10 from 
statistical analysis in this study, because his temperature 
was normal on day 1 and other clinical signs of illness were 
absent. His temporarily elevated RT is not unusual: normal 
body temperature in cattle can range from 100 to 108 oF 
depending on activity, environmental temperature and diurnal 
variation (Hicks, 1985). 
' 
RT may be an indication of the severity of BHV-1 
infection. Mean temperature increased gradually due to BHV-
1 infection, peaking 5 days after inoculation. On day o, 
(before BHV-1 inoculation), mean RT was 38.5oc. For the 
first 6 days following inoculation, RT averaged 38.6, 38.8, 
38.7, 39.1, 39.2, and 38.8°C, respectively. This corro-
berates the clinical observation that the infection was most 
severe on day 5. In previous studies, BHV-1 infection 
appeared to peak day 4 or 5 as judged by rectal temperature, 
clinical signs, and BHV-1 titers in nasal secretions 
(d'Offay and Rosenquist, 1986, 1988). 
Defense strategies versus virus growth. In inoculated 
animals, antibody and interferon production are associated 
with the growth cycle of BHV-1. Both are produced in direct 
response to the presence of BHV-1. The effectiveness of 
individual defense mechanisms depends in part on the method 
of spread of an individual virus, i.e., whether it spreads 
intra- or extracellularly. Intracellular spread can limit 
the effectiveness of antibodies which do not penetrate 
cells. Some defense strategies develop at an early stage 
following viral infection: these are important for limiting 
the extent of infection. Others are late to develop but may 
be important either in recovery to infections or in 
maintaining immunity to subsequent infections. 
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BHV-1 replicates in the nucleus of infected cells. The 
virus starts to appear in the nucleus four to six hours 
post-infection, and then enters the cytoplasm. The 
infective virus particle is formed by addition of a virus-
modified lipoprotein coat from the cytoplasmic membrane of 
the infected cell (CUrtis et al., 1966). Virus antigens on 
membranes of BHV-1 infected MDBK cells appeared on some 
cells by 4 hours PI, and on all cells by 7 hours PI. 
Infective viruses can be isolated from infected cells at 9 
to 10 hours PI, but are not released extracellularly until 2 
to 3 hours later (Babiuk et al., 1975). Herpesviruses can 
spread either intracellularly (type II spread) or extra-
cellularly (type I spread). In bovine cell cultures, BHV-1 
initially spreads only by the intracellular route, but two 
hours later extracellular viral spread occurs also (Rouse et 
al., 1976). Lysis of infected cells is more important for 
the spread of BHV-1, which is unusually cytopathic compared 
to other herpesviruses. 
Virus excretion. In our study, virus excretion was at 
high levels from day 2 to day 9 PI for all animals except 
for one calf which had completely eliminated the virus by 
day 9. Virus excretion was not measured on day 1. The peak 
mean virus titer occurred on day 4; lower titers were 
observed on days 5 and 7 (6.10, 5.33, and 5.70, respec-
tively). The lower virus titer on day 5 compared to day 4 
and day 7 titers may reflect the increased nasal discharqe 
at this time. The nasal discharqe was evident by day 4, and 
most profuse on day s. Alternately, the decrease on day 5 
may be due to differences in sample handlinq because BHV-1 
is sensitive to dryinq and temperature. 
Virus was first detected in the NS of calves 9 hours 
after intranasal inoculation with 109 PFU of BHV-1 {Cooper 
strain), and 14 hours after inoculation with 106 PFU (Lupton 
and Reed, 1980). Similarly, inoculation with 2 X 106 TCIDso 
(SO% total cell infection dose) of the vaccine strain 
resulted in hiqh BHV-1 titers at one day PI (d'Offay and 
Rosenquist, 1988). 
Experimentally, BHV-1 excretion in infected calves is 
limited to the first 7 to 11 days after infection (d'Offay 
and Rosenquist, 1988). However, the duration and extent of 
virus excretion may be affected by the initial virus dose, 
virulence of the virus, qenetics, and disease and 
nutritional history of the calves. 
Antibodies. In this study, we measured the serum 
antibody response to BHV-1 usinq two different analytical 
methods out of many possible procedures. Procedures for 
measurinq antibodies in body fluids can be cateqorized as 
primary and secondary bindinq assays. The primary assays 
are the most sensitive and directly measure the bindinq of 
antibody to antiqen. They include direct and indirect 
immunofluorescence assays, ELISA, and other enzyme 
immunoassays. Secondary bindinq tests tend to be easier to 
perform, but they are less sensitive. They measure the 
outcome of antibody-antigen binding such as precipitation, 
neutralization, hemagglutination, and complement fixation or 
activation. They can measure from lo-3 to lo-7 mg of 
protein per mL of fluid compared to as little as lo-8 mg 
protein per mL using primary tests {Hietala, 1989). 
In addition to the absolute quantity of specific 
antibody, any analytical method for an antibody is affected 
by the subclass and properties of the specific and 
nonspecific antibodies in serumi these change over time 
after an antigenic challenge. In respiratory tract 
infections, antibody titers in serum and nasal secretions 
can differ. The implication is that no single antibody 
method gives a comprehensive picture of the antibody 
response. Also, the analytical method and fluid selected 
for analysis is important. Typically in cattle exposed to a 
new antigen, the IgM class develops early, followed by the 
IgG class of antibodies. The IgM and the early IgG have 
relatively low affinity compared to the later IgG. However, 
IgA predominates in the seromucous secretions of the 
respiratory tract. 
The neutralizing antibody is one of the various types 
of antibody produced {others include precipitating, 
complement-fixing, and hemagglutination inhibition), but it 
has the most specific antibody reaction against viruses. 
Thus, the neutralizing antibody test is one of the most 
sensitive, specific and clinically significant serological 
tests (Peters and Bellanti, 1980). Agglutination methods 
readily detect IgM and are useful to detect early infection 
(Hietala, 1989). 
Neutralization refers to the loss of infectivity of a 
microorganism such as a virus after its interaction with 
specific antibody. Viruses have antigens located on their 
outer surface which are important for attachment to host 
cells. Neutralizing antibodies in body fluids or an mucosal 
surfaces can prevent viral attachment (Osburn and Stott, 
1989). 
The serum neutralization test is widely used for 
measurement of antibodies to many human and animal viruses. 
Neutralizing antibodies can persist in serum for long 
periods and therefore can be used serologically to determine 
prior exposure to viruses; paired sera showing either a 
four-fold increase in titer or seroconversion are necessary 
to diagnose a current infection. 
In our study, the neutralizing antibody response after 
virus inoculation was not different between treatments. 
Negative titers on day 0 indicated that the calves had not 
previously been exposed to BHV-1. Antibodies were not 
detected until day 14, similar to findings of Todd et al. 
(1972) and others, although very low levels of neutralizing 
antibodies were reported to occur as early as day 7 after 
vaccination with BHV-1 (Rouse and Babiuk, 1974). While 
one calf had not seroconverted by day 14, all calves had 
neutralizing antibody titers on day 28 greater than or equal 
to titers on day 14. 
Rossi and Kiesel (1976) found that calves produced 
neutralizing antibodies to BHV-1 in the IgM class followed 
by the IgG class in response to an i.m. injection of an 
attenuated strain of BHV-1. Also, during the first month 
PI, this antibody was primarily complement-requiring 
neutralizing antibody (CRNAb). No antibody was detected on 
either day o or day 4 PI. On day 9, CRNAb titers in the IgM 
class ranged from 32 to 512, and between 4 and 16 in the IgG 
class. In comparison, the titers without complement were 
much lower, between 1 and 16 for IgM and between 1 and 4 for 
IgG. On day 32 PI, antibody was primarily IgG and still 
predominatedly complement-requiring. Similarly, House and 
Baker (1970) observed a two to four-fold increase in titer 
when complement was used, equivalent to a .6 log increase in 
titer. They considered this of questionable significance 
compared to an error level in the test of .5 logs. In 
addition, they noted that the constant-serum varying-virus 
method of measuring neutralizing antibodies was 30 to 50,000 
times more sensitive than the routinely used constant-virus 
varying-serum version which we used. Compared to 
neutralizing titers against some other viruses, bovine 
titers to BHV-1 tend to be relatively low, making it harder 
to detect treatment differences. 
Our procedure for neutralizing antibodies would have 
measured only the non-CRNAb, because the sera were heat-
treated to inactivate complement as recommended by Carbrey 
et al. (1972). However, bovine serum is a poor enhancer of 
CRNAb; rabbit and guinea piq sera were equally qood 
enhancers (Rossi and Kiesel, 1976). 
Neutralizinq antibody titers to BHV-1 are first 
detected after peak virus titers and reach maximal 
concentrations late after infection at about 19 days (Rouse 
and Babiuk, 1974), whereas the virus usually is cleared 
between day 7 and day 11 PI. Therefore, neutralizinq 
antibodies may not be important in recovery, althouqh 
perhaps they are important in preventing infection from 
subsequent challenqes. Nonetheless, neutralizinq antibody 
was successful in reducinq virus dissemination in vitro more 
than 50-fold when rabbit complement was added every 2 hours 
(Babiuk, Wardley and Rouse, 1975). 
Serum IgG antibodies to BHV-1 were measured by the 
enzyme-linked immunosorbent assay (ELISA). In the area of 
infectious diseases, the ELISA is widely used to measure 
antibodies both for individual diagnosis of viral, 
bacterial, and parasitic diseases, and for epidemiological 
assessment of viral diseases. 
The basis of the ELISA is the use of an antibody or 
antigen which is linked to an enzyme, so that the complex 
retains both immunological and enzymatic activity. Thus, 
the technique utilizes the extraordinary ability of 
antibodies to discriminate amonq very closely related 
antigens, while the high enzyme activity allows 
amplification of the reaction by up to 105 times. 
The ELISA can be used to quantify any antibody if the 
appropriate antigen can be immobilized on a solid phase. 
Advantages of the technique include low cost, reagent 
stability, safety, sensitivity, and ease of procedure. 
However, for optimum reproducibility, ELISA tests must be 
rigidly controlled (Voller et al., 1980; Kurstak et al, 
1984). 
IgG titers could not be detected at day o or day 7 PI. 
Generally, the IgG response to an antigen appears 4 to 7 
days and peaks between 1 and 3 weeks post-exposure (Hietala, 
1989). On day 14, titers ranged from 100 to 800 in controls 
(mean 530), and from 100 to 1600 in +Vit calves. Four +Vit 
calves had titers of 1600, and the mean for +Vit calves was 
1120. The treatment difference approached significance (P = 
.115). If the titer (400) for control calf #13 had been 
included in the analysis, the difference would have been 
significant at P < .08. Titers at 28 days were similar for 
controls and +Vit treatments (1870 vs 2400; P > .05). 
However, when 14 and 28 day titers for each animal were 
averaged, titers in +Vit calves were higher than titers in 
control calves (1760 vs 1180, P < .09). Vitamin treatment 
appeared to influence the early IgG response; this could be 
biologically more significant than the later response. It 
would have been interesting to have found at what time IgG 
titers were detectable, and if there was a time difference 
due to treatment. 
The correlation observed between neutralizing antibody 
titers and ELISA IgG titers is not surprising. Both measure 
late antibodies, specifically IqG for the ELISA and 
predominately (at 14 and 28 days) IgG for the neutralizing 
antibody test. Collins et al. (1985) observed a linear 
correlation between neutralizing antibody titers (range 
<1/2-128) and ELISA titers (range 1/20-20,240), demon-
strating a 10 to 640-fold increase in sensitivity with the 
ELISA. While our data indicated that ELISA titers were 
about 100 times higher than neutralizing antibody titers, 
the ELISA was not necessarily more sensitive. However, it 
did detect IgG in the one animal which had no measurable 
neutralizing antibody titer at day 14. 
The ELISA may be more useful in detecting treatment 
differences than the neutralizing antibody test, due to its 
higher sensitivity. Depending on the specific antibovine-Ig 
utilized, it can be adapted to measure either IgG, IgM, or 
IgA in serum or nasal secretions. Initial differences in 
immunoglobulin production, particularly in local IgA at the 
site of viral challenge, may be important in limiting viral 
spread and in assisting recovery. Therefore, antibody 
titers early in the infection prior to viral clearance would 
be more meaningful as an assessment of treatment effects 
than levels at 14 days or later post-infection. 
Interferon. Interferon is an important early 
nonspecific immune response closely correlated with onset of 
recovery from BHV-1 infection. Interferons (IFN) are 
vertebrate proteins which are produced and released by cells 
in response to stimuli such as virus infection. IFN are 
biological regulators of cell function, with many diverse 
functions mediated through interaction with specific 
receptors on cell walls (Staeheli, 1990). They are 
extremely potent; the binding of one or a few molecules of 
IFN per cell is adequate to induce the many IFN-related 
effects (McMahon and Kerr, 1983). 
IFN suppresses the growth of many DNA and RNA viruses 
through the action of numerous IFN-induced proteins acting 
in concert and synergistically at several stages of virus 
growth (Staeheli, 1990). IFN converts susceptible, 
uninfected cells into cells resistant to virus challenge. 
The antiviral state takes several hours to develop in 
response to IFN, and normally lasts for two to three days. 
BHV-1 induced IFN in nasal secretions has protected cattle 
from subsequent challenge with BHV-1 (Todd et al., 1972; Le 
Jan and Asso, 1980) and infection with rhinovirus and 
parainfluenza-3 virus (cummins and Rosenquist, 1980; CUmmins 
and Rosenquist, 1982). 
In addition to their antiviral functions, IFN regulate 
natural and adapted immunity in many ways. They can enhance 
the cytotoxicity of immune T cells, NK cells and 
macrophages, stimulate lymphokine production, and alter 
lymphocyte responses. IFN modulate antibody production, and 
affect differentiation of B lymphocytes. Many changes in 
plasma membranes and cytoskeleton of cells in response to 
IFN have been identified, many of which can affect immunity. 
In our study, IFN was detected in nasal secretions of 
only 2 animals on day 2 PI. All animals had detectable IFN 
titers on day 4, with peak titers for both vitamin 
treatments occurring on day 7 PI. The relatively slow IFN 
response in this study is unusual; it may reflect the 
mildness of the viral infection due to use of a vaccine 
strain of BHV-1 and administering it by pipette rather than 
aerosol. In contrast, CUmmins and Rosenquist (1977) noted 
the highest serum IFN titers occurred on day 1 after BHV-1 
was inoculated intravenously at 107.8 median tissue culture 
dose of virus/kg body weight. Intranasal infection with 
avirulent BHV-1 induced low IFN titers in NS at 40 hours PI, 
and maximal titers at 4 to 6 days PI in one study (Todd et 
al., 1972) and, in another study, measurable levels in 3 of 
16 calves on day 1 PI, IFN titers in all calves by day 2, 
and maximal titers on day 7 PI (d'Offay and Rosenquist, 
1988). 
IFN titers tended to be lower on day 4 and higher on 
days 5 and 7 in the +Vit calves, but these differences were 
not significant (P <.05). The IFN concentration in early 
infection may be most important in limiting the severity of 
the infection, although IFN may be important in recovery 
after peak virus titers were reached on day 4 in both 
treatment groups. However, interferons have numerous 
functions in regulating the immune response other than 
through their antiviral activity; these may be equally 
important in limiting infection and assisting in recovery. 
Also, many other nonspecific factors including numerous 
cytokines also may be important. 
Dl 
Lymphocyte blastogenesis. The lymphocyte blastogenesis 
test (LBT) often is performed in survey experiments as an 
indicator of cell-mediated immunity (CMI). The temporal 
appearance of reactivity based on in vitro tests of CMI has 
been correlated with the onset of recovery to herpesviruses 
in domestic animals (Rouse and Babiuk, 1978). Further, 
recrudescence of BHV-1 in cattle treated with 
corticosteroids has been associated with depressed CMI, as 
measured by the LBT (Davies and Carmichael, 1973). 
LBT results are susceptible to large day to day 
fluctuations for individuals, nonspecific responses due to 
cross-reactivity or impurities of the test antigen, and the 
difficulties of maintaining cell viability in long-term cell 
cultures, especially microassay systems. Procedures and 
methods for reporting results suffer from the lack of 
standardization (Bellanti et al., 1980; Schultz, 1981). The 
presence of adherent macrophages is essential for maximal 
stimulation in this assay; failure to control macrophage 
numbers may be an additional source of variation. 
Either mitogens or antigens may be used to stimulate 
the lymphocyte blastogenesis. Mitogens are non-specific 
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activators; within any system they may stimulate 80-90% of 
cells. Common mitogens include phytohemagglutinin (PHA), 
concanavalin A (Con A), pokeweed mitogen (PWM) and bacterial 
lipopolysaccharides (LPS). Based on work with other 
species, PHA and Con A are believed to induce primarily a T-
cell response, PWM induces both a B and T cell response, and 
LPS induces a B cell response. However, various factors may 
influence the nature of the lymphocyte blastogenesis 
response (Schultz, 1981). 
some workers have used antigens rather than mitogens in 
order to generate a response specific to a virus or 
bacteria. For example, lymphocytes from cattle previously 
vaccinated or exposed to BHV-1, undergo blastogenesis in 
vitro when cultured with inactivated BHV-1. Lymphocyte 
blastogenesis was detected about 5 days after animals were 
intranasally infected with BHV-1, and peaked between 7 and 
10 days PI (Davies and Carmichael, 1973; Rouse and Babiuk, 
1974). Most antigens are T cell-dependent; therefore, the 
response is presumed to be a T cell response. But even if 
this is true, proliferation of T cells in vitro when exposed 
to an antigen may not correlate with CMI if the cells are 
primarily T helper cells, T suppressor cells, and(or) T 
memory cells, rather than T effector cells (Schultz, 1981). 
The LBT is often misused; it is not synonymous with CMI. It 
may have a relationship to CMI only if it measures a 
response by T effector cells. 
tl3 
In this study, variation within animals and sample 
periods was extremely high for the LBT; no clear trends were 
evident (Table 15). The stimulation index was significantly 
higher in the control calves in the initial sample taken 5 
days after arrival (day -15) and on day 7 postinfection. 
Because the LBT was higher for controls initially, even 
before vitamin treatments began on day -11, it is difficult 
to attribute the significant difference in LBT on day 7 to 
vitamin administration. 
The LBT procedure used involved the culture of the 
lymphocytes for 5 days in Dulbecco's Modified Eagle's Medium 
(DMEM) with fetal calf serum. DMEM contains various 
nutrients, including pyridoxine, while fetal calf serum 
contains variable nutrient levels depending on its source. 
Therefore, one major criticism of this assay for nutrition 
studies is that the provision of nutrients by the medium and 
serum could standardize the in vitro response. The in vitro 
response would be unrelated to the in vivo response if 
nutrition affected cell blastogenesis directly through 
availability of nutrients for replication rather than by 
affecting cell numbers, populations or other factors prior 
to stimulus. Only long-term deficiencies of some nutrients 
have been shown to affect lymphocyte populations or numbers 
in animals. 
The effect of nutritional status on the LBT has been 
investigated for selenium in livestock. Pooled serum from 
selenium-supplemented lambs enhanced blastogenesis of 
lymphocytes from both selenium-deficient and selenium-
supplemented lambs (Turner et al., 1985). Similarly, the 
LBT was markedly depressed when cells from vitamin 
Ejselenium deficient pigs were incubated with autologous 
serum, but blastogenesis was improved when fetal bovine 
serum was used instead (Lessard et al., 1991). Studies with 
cattle indicated that the selenium concentration in the 
culture as well as the ratio of cell numbers to selenium may 
be critical to the interpretation of in vitro assays of the 
immunomodulatory effects of selenium (Stabel et al., 1990). 
In vitro assays, particularly the LBT which is unique 
in involving extremely rapid growth and division of 
lymphocytes, may amplify nutritional requirements of the 
lymphocyte, and thereby may be inappropriate and completely 
unrelated to in vivo effects. This would be of greatest 
concern in nutritional studies involving short term changes 
in nutritional status. (Previous research indicating 
depressed CMI using the LBT in certain nutrient deficiencies 
have involved chronic nutrient deficiencies and depression 
of lymphocyte populations. In short-term deficiencies, the 
lymphocyte numbers may not be altered, even though 
proliferation in vivo may be nutrient-related). To a lesser 
extent, this concern may apply to other immunoassays 
involving cell culture. 
The LBT could be useful in nutritional studies if it 
could be adapted to assess how variation of nutrient 
concentrations in serum might impact on the ability of 
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lymphocytes or specific cell populations to undergo 
blastogenesis. One possible method would be to use an 
adapted medium lacking the nutrient(s) of interest, but 
supplemented with autologous serum from each animal tested. 
The lymphocytes used could also be autologous, or could be 
from a single animal. In order for this to work, normal 
serum from healthy animals would have to supply enough of 
the limiting nutrient to generate a proliferative response. 
This approach would allow one to investigate effects of 
limiting nutrients on cell proliferation, and determine 
which nutrients can alter proliferation. 
In addition to the LBT, the other two major in vitro 
tests of CMI to viruses are the macrophage inhibition factor 
(MIF) assay, and lymphocytotoxicity. All three of these 
possible parameters of CMI are positive earlier than humoral 
immunity in cattle infected with BHV-1, and their appearance 
tends to coincide with recovery (Rouse and Babiuk, 1978). 
The inhibition of macrophages (MIF) in vitro is 
correlated quite well with DTH to many antigens, but it is 
used infrequently to study CMI to viruses. The procedure 
depends on sensitized lymphocytes exposed to viral antigen 
releasing a soluble factor which inhibits macrophage or 
leukocyte migration. The MIF assay is extremely sensitive, 
but technical difficulties in performing the assay and 
nonspecificity due to qualitative differences in antigen 
preparations are drawbacks. 
In vitro lymphocyte-mediated cytotoxicity tests have 
been developed for numerous viral agents including BHV-1. 
These tests involve the interaction of specifically 
sensitized lymphocytes with viral antigens on the surface of 
an infected tissue culture line, leading to the lysis of the 
infected target cells. This can be measured in several 
ways, such as by the release of 51cr from the cells 
(Bellanti et al., 1980). 
As with the LBT, MIF and cytotoxicity assays may be 
inappropriate to measure in vivo responses to nutritional 
status. More appropriate in vivo tests would be desirable. 
In vivo tests of CMI include allograft rejection, delayed 
hypersensitivity skin test, and lymphocyte transfer. Some 
of the these techniques are useful in studies with 
laboratory animals using highly inbred lines; this has been 
impossible with ruminants. Delayed hypersensitivity skin 
tests have been used in some nutritional studies with 
cattle. Studies of CMI in ruminants would make the most 
rapid progress if a convenient bovine disease model could be 
identified in which CMI is shown clearly to affect infection 
or recovery. However, no clear CMI model for ruminants is 
available, unlike for mice in which CMI protects against 
ectromelia virus infection (Schultz, 1981). 
Many consider CMI important in recovery from virus 
infections including BHV-1 while humoral immunity is thought 
most important in preventing reinfection (Rouse and Babiuk, 
1978). Nonspecific aspects of immunity, both cellular and 
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humoral, may be critical in preventing initial infection and 
throughout the infection. For example, many cytokines 
including interferon are produced extremely early after 
infection and function to regulate the immune response, 
protect susceptible cells, and enhance cytotoxicity (Babiuk 
et al., 1991). Macrophages may be important in limiting 
viral dissemination (Rouse and Babiuk, 1978). Cytototoxic T 
cells sensitized to viral antigens reach peak activity about 
day 7 PI (Jakab, 1982), about the time virus titers begin to 
drop. Antibodies are detected at only low levels during 
virus recovery, peaking after the virus is eliminated. 
However, while low antibody concentrations are ineffective 
in neutralizing viruses, they may assist in recovery through 
antibody dependent cytotoxicity of antibody-complement cells 
lysis (Babiuk et al., 1975; Rouse et al., 1976a,b). 
Conclusions 
The BHV-1 infection in this study appeared to be very 
mild based on clinical signs. The virus successfully 
replicated in all calves, inducing an effective immune 
response in these calves. Previous research at o.s.u. has 
shown that effects of nutrition or management in stressed 
receiving calves are measurable only in batches of calves 
with a high incidence of morbidity to BRO. Similarly, it is 
possible that the mild infection in this study did not 
provide a rigorous test of treatment effects. 
Further, the viral-induced suppression of the immune 
system is crucial to the pathogenesis of BRD in stressed 
calves. Viral infections enhance adherence and colonization 
of bacteria in the respiratory tract, impair macrophage and 
neutrophil activity,and destroy the pneumocytes that secrete 
surfactants (Jakab, 1972; Babiuk, 1984; Yates, 1982). The 
effects of nutrition on this immune suppression are 
completely unknown. It also should be noted that the 
respiratory system is compartmentalized immunologically into 
upper, middle and lower areas with functional differences. 
Therefore, immune responses in the upper respiratory tract 
during BHV-1 infection may not relate to immune responses in 
the lung. 
One limitation of this study was that the stress model 
used may have caused insufficient stress. Stress itself may 
greatly affect a-vitamin requirements in the shipping-
stressed calf. Also, high plasma cortisol in stressed 
calves mediates immunosuppression through interaction with 
glucocorticoid receptors on leukocytes (Roth, 1985). High 
plasma cortisol levels cause altered function of 
neutrophils, macrophages and monocytes, and may affect 
concentrations of serum antibodies and various soluble 
immunorequlatory factors. 
One role for vitamin B6 is modulating the cortisol-
induced effects of stress; vitamin s6 may block cortisol the 
same way it affects other steroid hormones. steroid 
hormones affect expression of specific target genes through 
interaction with specific receptor proteins to form a 
complex. This complex localizes to the nucleus, associating 
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there with specific DNA sequences to modulate expression of 
certain genes (Allgood et al, 1990). Pyridoxal phosphate 
affects biochemical properties of steroid hormone receptors, 
subcellular localization and DNA binding capacity of these 
receptors. Animal studies indicate that translocation of 
steroid receptor complexes from the cytoplasm to the nucleus 
is enhanced by a vitamin B6 deficiency (Symes et al., 1984: 
Bunce and Vessal, 1987) and decreased by elevated vitamin 
concentrations (Holley et al., 1983). 
Different immune mechanisms appear to function and vary 
in importance at different times in the disease cycle of 
BHV-1 and other respiratory infections. Numerous specific 
and nonspecific mechanisms exist and the importance of many 
have not been elucidated for BHV-1 infections. The effects 
of nutrition, particularly B-vitamins, on these mechanisms 
in cattle is unknown. Our study focussed on specific immune 
mechanisms except for interferon during a primary virus 
infection. 
The implications of short-term versus long-term 
nutrient deficiencies should be considered. Although in 
this study we injected B-vitamins over a prolonged period, 
under practical conditions short-term nutrient defiencies 
(e.g. in the first 1 to 2 weeks after calves enter feedlots) 
appear most critical in affecting morbidity. B-vitamin 
dietary supplementation reduced the number of animals 
clinically diagnose as sick during the first 10 days of a 
trial (Zinn et al., 1987): similar results were reported 
1~ 
earlier by Cole et al. (1982). Perhaps investigations of 
nutrient interactions with immunity should focus on aspects 
of immunity which relate to the initial susceptibility to 
infection. Relatively late responses, such as neutralizing 
antibodies in this study, may be of lesser importance. 
In summary, infection and immunity were not affected by 
B-vitamin treatment as measured by BHV-1 titers and 
interferon in nasal secretions, neutralizing antibodies in 
serum, and clinical signs including rectal temperature. 
However, IgG titers on days 14 and 28 were higher (P <.09) 
in the +Vit calves than in control calves, indicating that 
the humoral immune response was enhanced by B-vitamin 
treatment. The high animal to animal variation for each 
assay suggests that a greater number of animals should be 
used per group in order to better detect treatment 
differences. Due to the complexity of the immune response, 
it is difficult to determine which of the many assays 
available should be used to assess nutritional effects on 
immunity. In order to survey effects of individual 
nutrients on immunity in cattle, studies may need to be far 
more comprehensive in scope. In particular, it may be 
important to investigate various components of innate 
immunity, and functions of both nonspecific and specific 
phagocytic cells, in addition to humoral immunity. 
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CHAPTER VI 
EFFECTS OF B-VITAMIN INJECTIONS ON PLASMA VITAMIN LEVELS IN 
FEED-RESTRICTED WEANED BEEF CALVES BEFORE AND AFTER 
INOCULATION WITH BOVINE HERPESVIRUS-! 
P. L. Dubeski, F. N. owens and w. o. Song 
ABSTRACT 
Six- to eight-month-old ~eef steer calves, limit-fed and 
fasted for 3 days during a 20-day period after weaning, were 
inoculated intranasally with live attenuated bovine 
herpesvirus-!. A mild respiratory infection developed in 
all calves 4 to 5 days after inoculation. The calves were 
injected with a B-vitamin mixture and ascorbic acid on 
alternate days every second day for 2 weeks prior to and 2 
weeks after inoculation. Vitamin injections increased 
plasma concentrations of ascorbic acid, folic acid, vitamin 
B12, pantothenic acid, and vitamin B6 (P < .002). Plasma 
concentrations of ascorbic acid, vitamin B12, pantothenic 
acid, and vitamin B12 , but not folic acid, were markedly 
reduced at the time the BHV-1 infection peaked, 5 days after 
BHV-1 inoculation. 
Introduction 
Stress is an important factor in the development of 
infectious disease such as the bovine respiratory disease 
complex which causes major economic losses to the cattle 
industry. Cattle are particularly vulnerable to disease 
during the first weeks after entry into feedlots, partly 
because stress during the shipping/marketing process can 
compromise the immune response. Stresses such as shipping 
can elevate serum cortisol levels for 4 to 7 days (Von 
Tungeln, 1986). Cortisol and other glucocorticoids have 
been shown to suppress the immune response in cattle and 
other species (Roth, 1985; Golub and Gershwin, 1985). 
1~ 
Cortisol mediates immunosuppression through interaction 
with glucocorticoid receptors on leukocytes (Roth, 1985). 
It impairs the function of neutrophils, macrophages and 
monocytes, inhibits cell mediated immunity, and can alter 
the concentration of serum antibodies and soluble 
immunoregulatory factors. 
Requirements for some water soluble vitamins, 
particularly pyridoxine, folic acid, pantothenic acid, and 
ascorbic acid, are believed to be increased by stress or 
disease (Mueller and Thomas, 1975). For example, the RDA 
Committee (1980) officially recognizes acute emotional and 
environmental stresses as conditions that increase the 
ascorbic acid requirement to maintain normal plasma levels. 
Requirements for vitamin B6 also may be increased by stress, 
as it may modulate the effects of cortisol through binding 
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to cortisol receptors (Maksymowych et al., 1990; Allgood et 
al., 1991). 
Both ascorbic acid supplementation and vitamin 86 
supplementation have helped to overcome cortisol-induced 
immunosuppression in man and experimental animals. Ascorbic 
acid improved the antibody response to SR8C in heat stressed 
or cortisol-treated chickens (Thaxton and Pardue, 1984; 
Pardue and Thaxton, 1984), reduced circulating glucocor-
ticoids in chickens, guinea pigs and man (Nockels et al., 
1973; Degwitz, 1987; Komindr et al., 1987), diminished some 
effects of dexamethasone on neutrophil function in cattle 
(Roth and Kaeberle, 1985), and potently stimulated in vitro 
lymphocyte blastogenesis at physiological concentrations 
(Panush and Dalafuente, 1979). 
Plasma levels of vitamin 86, folic acid, vitamin 812 , 
pantothenic acid and ascorbic acid were measured in cattle 
to investigate the effects of vitamin injections, restricted 
feeding and fasting, and 8HV-l infection. 
Materials and Methods 
Experimental Procedure. The experimental procedure was 
previously described (op cit Chapter 5). 
Blood Samples. All blood samples were collected by jugular 
venipuncture in 10 ml evacuated glass tubes (Vacutainers, 
Sherwood Medical, MO). Five blood samples (3 with potassium 
EDTA as an anticoagulant and 2 with sodium heparin as an 
anticoagulant) were collected for 8-vitamin analysis one 
month before weaning and on days -15, -8 (before fast), -5 
(end of fast), 0 (prior to BHV-1 inoculation), 7 (peak 8HV-1 
infection, and 14 (recovery from 8HV-1). 8-vitamin 
injections were discontinued and additional blood samples 
were collected on days 16 and 18 from +Vit calves only. 
When blood samples were taken for 8-vitamin analysis on the 
same days that 8-vitamins were injected, blood samples were 
obtained before injection. Cattle sometimes were sampled at 
1 day after injection, and sometimes 2 days after injection 
(Table 16). 
Vitamin Assays. Multiple samples of plasma were frozen at 
-20°C in appropriate aliquots for subsequent analysis of the 
water soluble vitamins. Samples were processed under very 
subdued liqhtinq to minimize photodegradation. Heparinized 
plasma for vitamin C analysis was added 1:1 to 10% (w/v) 
metaphosphoric acid prepared immediately before use. These 
samples were vortexed and frozen immediately. 
Vitamin c in heparinized plasma was measured using a 
colorimetric method involving 2,4-dinitrophenylhydrazine 
(McCormick, 1988). 
Folate and vitamin 812 plasma concentrations were 
measured in K2EDTA plasma using a radioassay kit for human 
samples (Quantaphase Folate and Vitamin 812 Radioassay, 8io-
Rad Clinical Division, Hercules, California). 
Pantothenic acid in heparinized plasma was measured 
using a sensitive indirect ELISA assay (Sonq et al., 1990). 
Table 16. Sampling date for a-vitamins versus number of 
injections and time since last injection 
Experimental day 
-15 (initial) 
-8 (before fast) 
-5 (before fast 
0 (aHV-1) 
5 (peak aHV-1) 
14 (end injections) 
16 (after injections) 























Each sample was assayed by two technicians, and results were 
averaged. 
The B6 vitamers were analyzed in heparinized plasma 
using ion-exchange reverse-phase chromatography with post-
column derivitization (Coburn and Mahuren, 1983). 
statistical Analysis. Plasma vitamin data were analyzed by 
analysis of variance models using the main effects of 
vitamin treatment and collection day. The effect of 
treatment was tested within each sample period using the 
animal within treatment mean square as the error term. 
Results and Discussion 
Ascorbic Acid. Plasma ascorbic acid concentrations 
were similar for the two treatment groups on day -15, before 
B-vitamin injections began (Table 17). The decrease (P < 
.39) in plasma ascorbic acid in control calves between day -
15 and day -a may be related ~o the negative energy balance 
in these calves. However, plasma ascorbate did not change 
in control calves due to fasting. Possibly the initial 
ascorbic acid levels were temporarily elevated due to stress 
of sampling so that values did not reflect true plasma 
levels. 
Stress due to handling and blood sampling is a common 
source of error in blood ascorbic acid levels for livestock 
species. Blood samples were taken after haltering the 
cattle and restraining their heads in order to take samples 
from the jugular vein. This procedure appears to be more 
stressful than sampling from a cannula which can be done 
153 
Table 17. Effect of experiment day and B-vitamin treatment on 











B-vitamins (d-8 vs d-15) 
Fasting (d-5 vs d-8) 
Refeeding (dO vs d-5) 
BHY-1 (d5 vs dO) 
Recovery from BHV-1 
(d14 vs d5) 
an = 6. 

























































without restraining the animal. Stressful procedures may 
elevate blood ascorbate due to release from the adrenal 
glands. After animals become accustomed to the handling, 
ascorbic acid levels do not respond. 
In humans, the major excretory route for ascorbic acid 
is the urine. When plasma concentration exceeds about 1.4 
mgjdL, substantial amounts of ascorbic acid appear in the 
urine (Jaffe, 1980). Plasma levels in man can be maintained 
as high as 4.0 mgjdL depending on the extent and frequency 
of ascorbic acid intake. The ascorbate body pool size in 
healthy adult human males is greater than 1400 mg; the range 
is from 900 to 17,000 mg. Daily turnover rate is about 60 
mgjday (Moser and Bendich, 1991). 
Plasma ascorbic acid in +Vit calves was not immediately 
increased by the injection of 1000 mg ascorbic acid every 2 
days. Ascorbic acid is carried nonspecifically in the blood 
and is taken up by organs using specific transport 
mechanisms to accumulate ascorbate. On day -a, the +Vit 
calves had received 2 ascorbic acid injections, the most 
recent being 2 days earlier, but plasma concentrations were 
the same as in control calves (0.70 mgjdL). This could be 
explained by repletion of ascorbic acid in some tissues. 
Ascorbic acid levels are several hundred times higher in the 
pituitary, adrenal, and thymus and 10 to 100 times higher in 
small intestinal mucosa, lymph glands, lung, liver, spleen, 
white blood cells and various other tissues than in plasma. 
At the end of the fast period (day -5), plasma ascorbic 
acid tended (P < .09) to be higher in the +Vit calves than 
in the controls. At this time the calves had been injected 
4 times, most recently being one day earlier. 
On day o, plasma ascorbic acid was much higher (P < 
.001) in +Vit calves compared to controls, 1.84 vs 0.74 
mg/dL, respectively. The magnitude of difference is 
surprising because calves previously had been injected 2 
days earlier, and one would expect plasma levels to peak 
before 2 days post-injection (PI) and then diminish due to 
renal clearance and(or) catabolism. Again, tissue release 
due to stress may partly explain the treatment effect. On 
day 0 and day -1 (practice day), nasal swab and tampon 
samples were first obtained. The cattle were haltered and 
restrained for these procedures, and then restrained again 
for blood sampling. Control calves may have had low 
ascorbic acid concentrations in the adrenals, whereas +Vit 
calves may have had much greater concentrations. Therefore 
stress due to the restraint may have markedly increased 
plasma ascorbic acid levels only in the +Vit calves. 
In both groups of calves, plasma ascorbic acid was 
reduced (P < .001) at the time of peak BHV-1 infection 
compared to on day 0, although levels tended to be higher in 
the +Vit calves (P = .07). The depression in plasma 
ascorbate due to BHV-1 has not previously been studied in 
cattle. However, in other species including man, ascorbic 
acid content of plasma and leukocytes has been reduced by 
disease, reflecting increased requirements during the immune 
response. 
Leukocytes contain very high levels of ascorbic acid 
compared to most tissues and plasma. Leukocytes can 
actively take up ascorbic acid during viral infection. 
Viral infections such as the common cold rapidly deplete 
ascorbic acid content of leukocytes (Wilson and Loh, 1973; 
Hume and Weyers, 1973). Ascorbic acid stimulates natural 
resistance. In vitro, ascorbic acid has been shown to 
enhance macrophage hexose monophosphate shunt activity, 
directed and random migration, and phagocytosis, and protect 
against the injurious effects of the toxic metabolites 
generated from macrophage activation (Ganguly et al., 1984). 
Ascorbic acid also enhances production of interferon, a 
complement component, serum immunoglobulins and antibodies 
in some animal and human models (Prinz et al., 1979: Siegel 
and Leibovitz, 1982). 
Recovery from BHV-1 had occurred by day 14; indeed, 
clinical symptoms were evident only for several days (day 4 
to 6) in most calves. Recovery from BHV-1 resulted in 
increased plasma ascorbic acid concentration in both groups 
of calves (P < .001). However, levels remained lower in 
controls than at any time prior to BHV-1 infection, and in 
+Vit calves compared to levels on days -5 and day o. This 
suggests that either requirements continued to be elevated 
or that repletion of tissues or leukocytes was continuing at 
the expense of plasma. 
After cessation of ascorbate injections, plasma 
ascorbic acid in +Vit calves dropped to levels lower than 
~7 
previously observed in control calves. In humans, increased 
ascorbic acid catabolism has been demonstrated for some time 
after discontinuation of macro-dosages of ascorbic acid. It 
has resulted in scurvy in humans receiving dietary ascorbate 
in normal amounts. Therefore, long-term administration of 
ascorbic acid at high levels should be used with caution. 
However, normal endogenous production of ascorbic acid by 
animals may greatly exceed normal human dietary 
requirements. 
Folic acid concentrations are shown in Table 18. B-
vitamin injections increased (P = .002) mean plasma folic 
acid concentration on day -8, and throughout the remaining 
part of the study. The folic acid dose was equivalent to 60 
mgjday; this is estimated to be 15 times the requirement. 
' 
In comparison, Girarde et al. (1989) injected 2 week old 
heifers with 2.5, 5.0, 10 and 20 mg folic acid, and 
successfully increased serum folate to 14.8 ngjmL, the level 
found in 4-month old heifers. Similar injections of 4-
month-old heifers did not affect serum folate, possibly due 
to the low dosage used. 
Girard et al. (1989) concluded that rapid renal 
clearance of excess folates maintained a constant serum 
folate of approximately 14 ng/mL in dairy heifers. The role 
of folate-binding proteins is not clear. Folate-binding 
proteins are found in serum at higher concentrations in 
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Table 18. Effect of experiment day and a-vitamin treatment on 











a-vitamins (d-8 vs d-15) 
Fasting (d-5 vs d-8) 
Refeeding (dO vs d-5) 
BHV-1 (d5 vs dO) 
Recovery from aHV-1 
(d14 vs d5) 
an = 6. 










































folate-deficient patients than in normal people; this may 
affect folate metabolism (Brody, 1991). Data from this 
study indicates that higher folic acid dosages than used by 
Girard et al. (1989) will increase plasma folic acid. 
However, the minimum dosage of injectable folic acid that 
will elevate plasma folic acid is not known. Perhaps folic 
acid was elevated only,because of the extremely high dosages 
used. However, similarly high concentrations (26.0 ngjmL) 
were observed in feedlot cattle (Table 4). 
In the control calves, plasma folic acid did not seem 
to be sensitive to feed intake, at least in the short term. 
Mean plasma folate was 11.8 ng/mL on day -15, after 5 days 
of restricted feeding. After an additional week of 
restricted feeding, it was 13.0 ngjmL. Following the 3-day 
fast, it was 13.1 ng/mL. Five days later, it was 10.1 
ng/mL. Plasma folic acid did not appear to be affected by 
fasting, nor did it decrease gradually as a result of the 
continued restricted feeding. 
BHV-1 infection did not decrease mean plasma folic acid 
in the control calves, which was 10.1, 10.9, and 12.2 ng/mL, 
respectively, for day o, day 5 (peak BHV-1), and day 14. 
The extremely high plasma folic acid concentration 
(410.8 ng/mL) in +Vit calves on day 0 is difficult to 
explain. These samples were taken 2 days after the previous 
a-vitamin injection. If plasma levels were increased more 
at 2 days instead of 1 day after intramuscular injection, 
similarly high concentrations also would be expected on day 
14, but this did not occur. Samples were analyzed in 
several different runs, and at different dilutions, ruling 
out experimental error. The extremely high folate levels 
may be an anomaly related to a combination of factors such 
as high tissue levels, effects of stress during sampling, 
and(or) delay in processing of the blood samples. The 
folate concentration in erythrocytes of normal humans is at 
least 25 times higher than the serum folate concentration. 
Hemolysis must be avoided when measuring plasma or serum 
levels. If folate injections dramatically elevate 
erythrocyte folate concentrations, even minor hemolysis or 
leakage of folate frqm erythrocytes could affect plasma 
levels. 
Because of the unusually high plasma folic acid for 
+Vit calves at day o, the drop at day 5 may not have been 
caused by BHV-1 infection. The contrast for BHV-1 was 
signficant (P=.002) as folate increased in controls but 
decreased markedly in +Vit calves. If BHV-1 had increased 
folic acid requirements, plasma folic acid should have 
decreased in controls as well. Also, the mean day 5 plasma 
folic acid concentration was very similar to that for days 
-a, -5, and 14 (29.4 vs 28.3, 32.8, and 28.2 ng/mL, respec-
tively). Therefore, it appears that plasma folic acid may 
not be affected by a mild BHV-1 infection. 
Relatively high plasma folic acid concentrations (6.4 
to 14.5 ngjmL) in stessed calves in the earlier study (Table 
4) also suggest that folic acid status may not be seriously 
depressed by stress and reduced intake. Nonetheless, it 
would be interesting to check folic acid status in sick 
feedlot cattle which have developed either an acute viral 
infection or bacterial pneumonia following a primary viral 
infection. 
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Vitamin B12• Plasma vitamin B12 results are shown in 
Table 19. Short term changes in plasma s 12 have not been 
investigated except in response to injection. The plasma 
B12 observations for the control calves are interesting. 
While the mean plasma B12 concentration in suckling beef 
calves was 229 pgjmL, the initial a12 concentration at day -
15 following 6 days of restricted feeding was 298 pgjmL. 
Plasma B12 further increased on days -a, -5, and reached the 
maximum concentration on day 0 (301, 373, and 408 pgjmL, 
respectively). This can be explained by the observation 
that starvation tends to increase B12 concentration in liver 
and kidney (Andrews and Hart, 1962). Plasma concentrations 
therefore also should be increased by starvation because 
plasma, liver and kidney concentrations are positively 
correlated. Tissue vitamin B12 stores in cattle, similar to 
humans, may be a thousand times greater than daily 
requirements. Liver and other organs contain high 
concentrations; the volume of gut tissues, including liver, 
is decreased when cattle move to a lower plane of nutrition, 
and vice versa. 
While weight loss increases plasma B12' increased 
requirements would work in the opposite direction. This was 
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Table 19. Effect of experiment day and B-vitamin treatment on 











B-vitamins (d-8 vs d-15) 
Fasting (d-5 vs d-8) 
Refeeding (dO vs d-5) 
BHV-1 (d5 vs dO) 
Recovery from BHV-1 
(d14 vs d5) 
an = 6. 











































observed on Day 5, when plasma B12 dropped 31% in controls 
from 408 to 281 pg/mL. Plasma B12 concentration had 
recovered to 376 pgjmL at day 14, reflecting both decreased 
requirements and an increased supply, as feed intake was 
increased to maintenance levels from day 3 to day 14. 
The role of vitamin B12 status in resistance to disease 
is not clear. Research in humans has centered on the 
autoimmune phenomena in pernicious anemia. Animal studies 
are limited due to difficulties in producing an absolute 
deficiency in experimental animals. However, s 12 defi-
ciencies in ruminants can occur within months of feeding a 
cobalt-deficient diet, whereas it can take several years of 
a vegetarian diet to produce a vitamin B12 deficiency in 
man. Consequently, the ruminant could be a useful model for 
B12 metabolism. 
The reason for the fall in plasma B12 due to BHV-1 is 
not known. s12 requirements are interrelated with folate, 
methionine and choline requirements (Nauss and Newberne, 
1981). 
In +Vit calves, plasma s12 tended to be increased over 
that in controls at day -8 (P = .07) and plasma B12 was 
elevated (P < .01) in +Vit calves compared to controls on 
subsequent days. As occurred for plasma folate, B12 levels 
were extremely high on day o (2165 vs 408 pgjmL in +Vit vs 
control calves, respectively). Hemolysis does not appear to 
be a problem with plasma vitamin B12 analysis (Bio-Rad, 
1989). The peak blood vitamin levels on day 0 in injected 
1~ 
calves may have occurred naturally due to the gradually 
increasing vitamin status. Once tissues were saturated, 
plasma levels can increase at a very high rate. If so, then 
the decrease in plasma B12 (and similarly, other a-vitamins) 
on day 5 indicates a drastic change in vitamin metabolism or 
distribution due to BHV-1. The plasma B12 concentration was 
higher (733 pg/mL) on day 14 than on day 5 (618 pg/mL), and 
similar to the means for day -5, day 0 and day 14 (373, 408, 
and 376 pg/mL, respectively). If there is a rapid-turnover 
B12 pool which is depleted during infection, plasma B12 
levels in +Vit calves would be expected gradually to attain 
levels as high as were observed on day 0. Unfortunately, 
injections were terminated on day 14 so this could not be 
tested. 
Pantothenic Acid. Plasma pantothenic acid 
concentrations appeared to be sensitive to restricted intake 
and fasting, and BHV-1 infection, but responded slowly to B-
vitamin injection (Table 20). 
Mean plasma pantothenic acid was relatively high (.190 
nM) on day -15 in both control and +Vit calves, compared to 
means of .138 and .095 previously observed in suckling and 
stressed calves, respectively. In both groups, day 5 plasma 
pantothenate was lower than at any other time. In both 
groups, plasma pantothenate rebounded on day 14, possibly 
due partly to increased feed intake levels as well as 
recovery from BHV-1. 
Table 20. Effect of experiment day and B-vitamin treatment on 











B-vitamins (d-8 vs d-15) 
Fasting (d-5 vs d-8) 
Refeeding (dO vs d-5) 
BHV-1 (d5 vs dO) 
Recovery from BHV-1 
(d14 vs- d5) 
an = 6. 
































Vitamin B6. B6 vitamers were measured in plasma 
samples taken on days -15, o, and 5 only (Table 21). Total 
B6 was similar in both treatment groups before a-vitamin 
treatments began (day -15). However, pyridoxal phosphate 
(PLP} was higher and pyridoxal (PL) lower in control 
compared to +Vit calves. This may be due to variable 
hydrolysis of PLP to PL during a prolonged storage period 
(approximately one year). Stability of a 6 vitamers was a 
major concern due to lack of data on stability in bovine 
plasma. Freezing rat plasma at -20°c for 55 weeks did not 
affect B6 content; however, these workers hydrolyzed the 
phosphate esters of the B6 vitamers using a potato acid 
phosphatase before chromatography, so breakdown of PLP to PL 
was not assessed (Hefferan et al., 1986). 
Dr. Coburn suggested that total B6 as well as PLP may 
be depressed in the samples due to degradation in storage. 
Using a similar HPLC method, Coburn et al. (1984) measured 
plasma PLP concentrations of 402 ± 131 nM in 3 older calves, 
or 308 ± 67 nM measured enzymatically. PLP was the primary 
a6 vitamer in calf plasma. Based on this limited evidence, 
our PLP and total a6 concentrations appear very low. 
Compared to samples from stressed calves analyzed 
simultaneously (Table 5), the day -15, 0 and 5 samples all 
are higher in total a6 , lower in PLP, and higher in PL. The 
stressed calf samples were stored only half as long. These 
data suggest that longer storage did cause hydrolysis of PLP 
to PL, but may not affect total B6· Total B6 was lower in 
Table 21. Effect of experiment day and B-vitamin treatment 
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bsefore B-vitamin injections began. 
ccalves inoculated intranasally with 107 PFU BHV-1 on 
day o after blood samples taken. 
dDay 5 = Peak BHV-1 injection. 
econtrast compares B6 vitamers before B-vitamin 
treatment (day-15) and after B-vitamin treatment began 
(dats o and 5). 
Contrast compares B6 levels before BHV-1 injection 
(day 0) and at peak BHV-1 injection. 
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stressed calves than in the day -15 calves (133 vs 204 nM). 
Evidently, severe stress incurred during the shipping and 
marketing process may depress vitamin s6 status in calves. 
The effect of a-vitamin injection was analyzed using 
the contrast day -15 versus day 0 plus day 5. a-vitamin 
treatment affected PL, 4-pyridoxic acid (PA), total s6 (P < 
.001), and pyridoxine (PN; P < .006). The interaction of 
the effects of BHV-1 and a-vitamin treatment also was 
significant for these vitamers, so effects of a-vitamin 
treatment will be discussed separately for day 0 and day 5. 
On day o, PL, PN, PA and total B6 all were higher (P < 
.002) in plasma from +Vit than control calves. PLP was not 
different (P = .94). Plasma from injected calves contained 
high levels of pyridoxine because pyridoxine hydrochloride 
was the B6 source injected. It is converted into the other 
B6 vitamers. Plasma from +Vit calves also contained 
extremely high amounts of 4-pyridoxic acid, a major s6 
metabolite in many species that is excreted in the urine. 
Compared to day -15, on day 0 total s6 was lower in 
control calves but higher in +Vit calves (interaction P < 
.001). Total B6 may have fallen in controls due to 
diminished supply with restricted feeding because B6 supply 
is correlated with intake (Zinn et al., 1987). Conversely, 
vitamin s 6 was supplied at eight times the estimated 
requirements by injection for +Vit calves. Because these 
estimates were designed to meet elevated requirements due to 
stress and disease, they would be excessive for the 
relatively unstressed animals in this study. 
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Plasma and tissue concentrations of a6 vitamers may be 
highly sensitive to changes in supply. Blood and tissue 
levels were reduced 10 to 90% in rats by feeding a a6 defi-
cient diet for only 2 weeks (Sampson and Connor, 1989). In 
contrast, fasting healthy male dogs for 40 hours decreased 
plasma PLP by 15%, and increased PL by 20%; baseline levels 
again were achieved by 48 hours after refeeding (Barnard et 
al., 1986). 
Various studies indicate that plasma PLP is derived 
primarily from recent dietary vitamin B6 intake, 
particularly pyridoxine, and little PL is recycled through 
the liver into PLP in plasma (Coburn et al., 1992). The 
similar PLP concentrations in the two treatment groups on 
day o, and higher levels of PL in +Vit calves (645 vs 93 nM, 
P < .001) provide evidence that PLP in plasma was degraded 
to PL during sample storage. 
Total a6 and all vitamers were lower in both control 
and +Vit calves on day 5 than on day o. The most striking 
observation was the almost complete absence of PN from 
plasma of +Vit calves; only one calf had a detectable 
content of PN (57 nM). similarly, both 4-pyridoxic acid and 
total a6 were extremely depressed by BHV-1 infection in +Vit 
calves compared to control calves. PL ~as depressed in both 
treatment groups as well. 
1~ 
These observations indicate that B6 metabolism is 
markedly affected by infection. Plasma concentrations were 
reduced, B6 excretion appeared to be reduced, and s6 may be 
taken up by tissues (leukocytes) at the expense of plasma 
levels. This may indicate an adaptive process rather than a 
deficiency (Wilson and Davies, 1983). Alternatively, 
changes in vitamin status or metabolism due to a viral 
infection may contribute to the animal's subsequent 
susceptibility to other infections. 
In conclusion, a very mild BHV-1 infection markedly 
depressed plasma concentrations of ascorbic acid, vitamin 
B12r pantothenic acid, and vitamin B6 but not folic acid, at 
5 days post-infection. Restricted intake and a 3-day fast 
decreased plasma levels of vitamin B6 and pantothenate, and 
increased plasma B12, but did not appear to affect blood 
plasma folic acid and ascorbic acid concentrations. 
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Appendix A. Effect of a-vitamin treatment on rectal temperature of calves before and after 
inoculation with aHV-1 on day 0 
Days 
Calf 
Treatment No. -20 -19 -18 -17 -16 -15 -14 -13 -12 
Control 
3 38.9 39.1 39.1 39.1 38.9 38.6 38.8 38.9 38.9 
5 38.9 38.9 38.9 39.1 39.0 38.7 38.8 38.7 38.7 
6 39.1 39.1 38.9 38.9 38.8 38.8 38.9 38.6 38.8 
8 38.9 39.0 39.0 39.0 38.8 38.6 38.4 38.8 39.0 
10 39.3 39.4 39.1 39.2 39.1 38.9 38.8 38.9 38.8 
11 38.7 38.9 38.8 38.9 38.8 38.7 39.1 38.7 39.0 
L.S. Mean 38.90 39.02 38.93 38.87 38.88 38.6 38.80 38.64 38.79 
a-vitamin 
1 38.9 39.1 38.9 38.6 38.6 38.6 38.6 38.4 38.8 
2 39.2 39.0 38.8 38.8 38.9 38.6 38.5 38.5 38.9 
4 39.1 38.9 38.8 39.1 38.3 38.8 38.6 38.7 39.1 
7 38.9 38.9 38.7 38.2 38.9 38.4 38.6 38.1 38.4 
9 38.7 38.9 38.7 39.0 38.7 38.6 38.7 38.5 38.8 
12 39.0 39.0 38.7 39.1 38.9 39.1 38.7 38.8 39.1 
L.S. Mean 39.05 39.02 38.77 38.94 38.73 38.78 38.63 38.63 38.92 
Mean 38.98 39.02 38.85 38.91 38.81 38.69 38.71 38.63 38.86 
S.E. 0.08 0.06 0.04 0.11 0.08 0.08 0.07 0.09 0.08 
Appendix A. Effect of B-vi tan:! , treatment on rectal temperature of calves before and 
after inoculation -'dth BHV-1 on day o (continued) 
Days 
Calf 
Treatment No. -11 -10 -9 -8 -7 -6 -5 -4 -3 
Control 
3 38.7 39.4 38.7 38.6 38.4 38.3 38.7 38.7 38.9 
5 38.9 38.7 38.6 38.2 38.2 38.1 38.3 38.4 38.5 
6 38.8 39.7 38.7 38.4 38.6 38.4 38.8 38.7 38.7 
8 38.8 39.4 38.9 38.6 38.6 38.1 38.8 38.9 38.7 
10 39.2 39.1 38.8 38.8 38.6 39.4 39.2 39.1 39.5 
11 38.9 39.1 38.5 38.5 38.6 38.2 38.8 38.6 38.8 
L.S. Mean 38.79 39.20 38.63 38.44 38.53 38.29 38.65 38.60 38.72 
B-Vitamin 
1 38.4 39.3 38.7 38.2 38.6 38.4 38.5 38.3 38.3 
2 38.7 39.3 38.6 38.5 38.3 38.3 38.4 38.3 38.7 
4 38.7 38.6 38.8 38.3 38.2 38.2 38.4 38.6 38.2 
7 38.3 38.7 38.6 38.2 38.4 38.0 38.0 38.0 38.4 
9 38.6 39.3 38.6 38.2 38.3 37.8 38.5 38.6 39.0 
12 38.9 39.3 38.8 38.3 38.1 37.9 38.7 38.7 39.0 
L.S. Mean 38.71 39.12 38.72 38.33 38.28 38.24 38.56 38.54 38.76 
Mean 38.75 39.16 38.68 38.39 38.40 38.26 38.61 38.57 38.74 









A. Effect of B-vitamin treatment on rectal temperature 
after inoculation with BHV-1 on day 0 (continued) 
Days 
Calf 
No. -2 -1 -o 1 2 3 
3 39.0 38.5 38.5 38.4 38.8 38.4 
5 38.7 38.4 38.7 38.6 38.8 38.7 
6 38.6 38.8 38.3 38.6 38.9 38.7 
8 39.1 38.7 38.6 38.8 38.9 38.7 
10 39.4 40.7 39.3 39.5 39.2 39.3 
11 39.1 38.7 38.2 38.9 39.2 38.8 
Mean 38.88 38.68 38.46 38.65 38.92 38.71 
1 38.5 38.3 38.3 38.3 38.4 38.5 
2 38.7 38.5 38.4 38.3 38.6 38.3 
4 38.9 38.4 38.6 38.7 38.8 39.1 
7 38.7 38.1 38.2 38.2 38.7 38.6 
9 38.9 38.6 38.5 38.4 38.9 38.8 
12 38.9 38.8 38.5 38.7 38.8 38.6 
Mean 38.87 38.74 38.54 38.60 38.74 38.73 
Mean 38.88 38.71 38.50 38.62 38.83 38.72 
S.E. 0.10 0.25 0.12 0.13 0.07 0.12 
of calves before and 
4 5 6 
38.6 38.7 38.7 
40.2 39.1 38.5 
38.7 39.3 38.9 
39.1 39.8 40.1 
39.3 39.7 39.1 
38.5 38.7 38.6 
38.88 39.15 38.93 
38.8 39.9 38.4 
39.4 38.4 38.8 
38.3 38.7 38.4 
38.9 39.4 38.7 
38.8 38.5 38.2 
40.4 40.1 39.1 
39.30 39.23 38.63 
39.09 39.19 38.78 
0.27 0.25 0.19 
I 
/ Appendix B. Effect of a-vitamin treatment on rectal temperature of calves before and 
after inoculation with BHV-1 on day o (continued) 
Days 
Calf 
Treatment No. 7 8 9 10 11 12 13 14 
Control 
3 39.0 38.6 38.5 38.7 38.9 38.6 38.3 N/A 
5 38.4 38.3 38.7 38.7 38.8 38.4 38.2 N/A 
6 39.2 38.6 38.8 38.9 39.2 38.6 38.4 N/A 
8 38.9 38.2 39.0 38.7 38.9 38.6 38.6 N/A 
10 39.2 38.3 39.1 38.9 39.0 38.5 38.6 N/A 
11 39.1 38.8 39.3 38.8 39.2 38.6 38.7 N/A 
L.S. Mean 38.87 38.51 38.83 38.69 38.98 38.49 38.44 N/A 
B-Vitamin 
1 38.6 38.1 38.1 38.4 38.5 38.3 38.3 N/A 
2 38.6 38.3 38.5 38.5 38.5 38.2 38.4 N/A 
4 38.8 38.4 38.4 38.6 38.8 38.5 38.3 N/A 
7 38.5 38.2 38.6 38.2 38.9 38.3 38.4 N/A 
9 38.2 38.3 38.6 38.3 38.9 38.4 38.3 N/A 
12 38.9 37.9 38.9 38.8 39.1 38.7 38.6 N/A 
L. s. Mean 38.66 38.19 38.56 38.58 38.81 38.46 38.42 N/A 
Mean 38.76 38.35 38.69 38.63 38.89 38.47 38.43 N/A 
S.E. 0.11 0.09 0.12 0.07 0.08 0.06 0.07 N/A 
Appendix B. Effect of period and B-vitamin treatment on 
lymphocyte blastogenesis. 



































































































































































a,~eans in the same column with different superscripts 
differ (P < .05). 
cData omitted in statistical analysis due to very low 
stimulation indices for this animal. 
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Appendix B. Effect of period and a-vitamin treatment on 
lymphocyte blastogenesis (continued) 
Lymphocyte Blastogenesis Data 
Calf Blank Low Medium High 
Day Treat No. (cpm) S.I. S.I. S.I. 
5 Control 3 195.7 929.8 1007.9 1234.1 
After 5 107.0 1417.0 1584.5 2039.4 
BHV-1 6 51.7 3154.8 3806.5 4487.6 
Inoculation 8 176.2 323.6 267.3 454.2 
10 156.5 1006.4 1097.1 1220.9 
11 96.2 1628.2 1737.1 2149.3 
Mean 141o.oa 1583.3a 1930.8a 
a-vitamins 1 183.5 42.9 58.5 64.6 
2 129.2 100.9 137.4 147.7 
4 119.0 224.4 266.2 263.5 
7 154.8 163.9 159.7 189.8 
9 450.7 495.4 505.5 558.8 
12 235.5 297.2 424.3 437.9 
Mean 220.7b 258.5b 277.3b 
Mean 815.3 920.9 1104.1 
S.E 282.7 351.7 407.1 
7 Control 3 98.2 16.1 23.7 41.3 
After 5 155.0 2.7 6.0 5.8 
BHV-1 6 85.2 85.0 149.7 402.7 
Inoculation 8 299.8 13.5 18.1 27.1 
10 146.2 383.5 506.4 784.8 
11 497.0 211.5 324.3 412.9 
Mean 142.0 204.4 333.8 
a-vitamins 1 156.0 969.3 901.3 940.9 
2 109.0 17.4 25.5 44.8 
4 102.8 17.9 25.2 40.1 
7 100.5 571.8 509.3 728.9 
9 391.0 492.4 497.8 487.0 
12 81.2 578.2 1179.4 1930.0 
Mean 441.0 522.8 695.3 
Mean 305.1 378.1 531.0 
S.E. 119.8 151.9 230.8 
a,bMeans in the same column with different superscripts 
differ (P < • 05) • 
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Appendix B. Effect of period and B-vitamin treatment on 
lymphocyte blastogenesis (continued) 
Lymphocyte Blastogenesis Data 
Calf Blank Low Medium High 
Day Treat No. (cpm) S.I. S.I. S.I. 
14 Control 3 227.8 10.2 15.5 55.3 
After 5 95.2 506.5 746.0 1265.1 
BHV-1 6 76.0 370.0 590.7 1686.4 
Inoculation 8 190.3 57.3 61.6 48.2 
10 206.5 363.0 467.3 380.6 
11 147.5 1045.3 760.9 641.4 
Mean 391.8 440.5 679.3 
B-Vitamins 1 118.2 443.7 447.3 669.8 
2 153.5 26.4 30.3 30.9 
4 78.2 62.8 74.7 74.4 
7 136.8 226.6 185.0 148.8 
9 372.5 88.6 86.2 98.0 
12 145.2 705.6 598.1 344.5 
Mean 257.5 236.8 227.7 
Mean 324.7 338.7 453.5 
S.E. 132.4 116.3 205.3 
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